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Abstract: Loss of photoreceptors due to retinal degeneration is a major cause of blindness 
in the developed world. While no effective treatment is currently available, cell replacement 
therapy, using pluripotent stem cell-derived photoreceptor precursor cells, may be a feasible 
future treatment. Recent reports have demonstrated rescue of visual function following the 
transplantation of immature photoreceptors and we have seen major advances in our ability 
to generate transplantation-competent donor cells from stem cell sources. Moreover, we are 
beginning to realise the possibilities of using endogenous populations of cells from within the 
retina itself to mediate retinal repair. Here, we present a review of our current understanding 
of endogenous repair mechanisms together with recent progress in the use of both ocular 
and pluripotent stem cells for the treatment of photoreceptor loss. We consider how our 
understanding of retinal development has underpinned many of the recent major advances 
in translation and moved us closer to the goal of restoring vision by cellular means. 
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1. Introduction  
 
As visual animals, our sight is often regarded as our most important sense, with almost 30% 
of the sensory input to the brain originating from the retina (Dowling.J.E., 2012; Rodieck, 
1998). It makes the loss of this sense a devastating one. Lower vertebrates possess an 
incredible intrinsic capacity for repair throughout their bodies, including complex neural 
structures like the retina. The mammalian neural retina, however, like many other regions of 
the central nervous system (CNS), lacks any significant regenerative potential to replace lost 
neurons after retinogenesis is complete. Consequently, any damage leading to the death of 
the light sensing photoreceptor cells or their support cells, either through injury or disease, 
typically leads to permanent visual impairment. The past decade has seen significant 
progress in our understanding of the underlying molecular mechanisms for a broad range of 
retinal diseases. Nonetheless, current clinical treatment options are limited to delaying the 
onset or decelerating the progress of the condition. To address this, extensive research 
effort has focused on the development of novel therapeutic strategies. These include, 
amongst others, attempts to replace damaged cells by transplantation and strategies for the 
reactivation of endogenous stem cell populations to generate new photoreceptors. The 
regenerative ability of lower vertebrates has led researchers to investigate the mechanisms 
underlying these repair pathways to see if the same principles apply in mammals, including 
humans. Promisingly, a number of studies have demonstrated that some limited 
regenerative capacity remains in specific regions and cell types in the mammalian eye, 
including the ciliary epithelium (CE), retinal pigmented epithelium (RPE), iris and Müller glia 
cells.  Endogenous repair is a very attractive strategy and a number of approaches have 
been employed to attempt to reactivate these cells in vivo (Figure 1a). Thus far, the 
efficiency of reactivation and the potential of the newly generated cells are currently low and 
insufficient for the widespread repair of the mature mammalian eye following injury or 
disease. There remains much scope for improvement in this area, however. Moreover, in 
vitro culturing of these cells has yielded more hope that they might serve as a source of 
donor cells for cell replacement therapies (Figure 1b). Effective cell replacement involves the 
identification of a renewable source of donor cells that have the ability to migrate into and 
correctly integrate within the recipient retina with high efficiency. Therefore, as well as 
focusing on ocular stem/progenitor cell niches, we also consider the different types of 
pluripotent stem cells available for transplantation purposes and our understanding 
regarding their potential to generate retinal cell types  (Figure 1c-d).  
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2. Retinal Degeneration 
 
Retinal degeneration is caused by the progressive loss of the sensory cells of the retina, the 
photoreceptors, and accounts for approximately 50% of all cases of blindness in the 
developed world (Bunce et al., 2010). Broadly, they fall into three forms: rod-degenerative 
forms, mixed rod/cone-degenerative forms or debris-associated forms (e.g. mertk defects 
and light damage). There are many causes of degeneration, primarily hereditary conditions 
and age related effects, but also diabetic retinopathy or retinopathy of prematurity.  
 
Visual loss from inherited disease includes conditions such as retinitis pigmentosa (RP), 
choroideremia, Leber Congenital Amaurosis, Stargardt disease and Ushers disease and can 
arise from mutations in more than 200 different genes [see 
http://www.sph.uth.tmc.edu/Retnet/; (Hartong et al., 2006)]. As a result, the onset of 
hereditary disease and the speed of progression can be highly variable, depending upon the 
specific condition. This contrasts with age-related macular degeneration (AMD), which 
usually affects older adults (Minassian et al., 2011; Owen et al., 2012; Taylor, 2005).  
Currently, there are few effective treatments meaning that these conditions not only present 
a high socio-economic burden for patients and their families, but also for the healthcare 
system as a whole (Koberlein et al., 2013).  
 
Of the retinal degenerative diseases, RP is perhaps the best characterised (Bird A, 1995), 
with an incidence of 1 in 3,500-4,000 (Bunker et al., 1984). This group encompasses 
significant genetic and phenotypic heterogeneity. A wide variety of causes have been 
attributed; these include disruption of a number of genes that are involved in 
phototransduction, including the biosynthesis and folding of the photopigment molecule, 
Rhodopsin, as well as primary failure of the support cells within the retina, particularly the 
RPE. This heterogeneity means that RP has a highly variable clinical presentation and 
progression. However, the majority of patients initially experience problems in night vision, 
since the rod photoreceptors are typically damaged first, and a progressive loss of peripheral 
vision, leading to tunnel vision. In many cases, this can progress to include the central visual 
field and blindness (Hartong et al., 2006). 
 
AMD is the leading cause of irreversible blindness in people over the age of 55 (De Jong, 
2006) and almost two-thirds of people aged 80 or over show signs of AMD. AMD is a highly 
complex disease and the mechanism of AMD pathogenesis has not yet been delineated. It is 
influenced by both genetic and environmental factors. At least 34 different genetic loci are 
associated with AMD, with the involvement of multiple pathways. A range of single 
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nucleotide polymorphisms in genes affecting components of the innate immune system, 
such as complement factor H, complement factor B or C3, has been strongly linked with the 
disease (Haines et al., 2005; Klein et al., 2005). Modifiable risk factors, such as smoking, 
diet, cardiovascular disease, high body mass index (BMI), serum cholesterol levels, 
hypertension and sunlight exposure have also been implicated (Evans, 2001). 
  
AMD is thought to arise as a result of a chronic, low-grade inflammation in the outer neural 
retina, particularly around the macular region in the central retina. This leads to a 
degeneration of the RPE and its basement membrane, Bruch’s membrane (Jager et al., 
2008). Like the conditions described above, it culminates in the loss of both rod and cone 
photoreceptors, although the cone-rich macular is most severely affected. Vision is lost 
either from a relatively slow process of photoreceptor death (‘dry’ or geographic atrophy) or 
from a more rapid and destructive process of neovascularization through Bruch’s membrane 
and the RPE into the subretinal space and, occasionally, the retina (‘wet’ or choroidal 
neovascular AMD). The resulting damage to the macular region leads to a loss of vision in 
the central visual field. Recent years have seen a major advance in the treatment of 
neovascular forms of AMD, with the use of anti-vascular epithelial growth factor (VEGF) 
drugs, which act to reduce or reverse the neovascularisation [reviewed in (Finger et al., 
2014)]. However, the dry form of AMD is more common and, like RP, there are few 
treatment options.  
 
Despite the very diverse aetiologies encompassed within the different retinopathies 
mentioned above, they share a common outcome: photoreceptor loss. Perhaps surprisingly, 
much of the underlying structure of the retina, including the second and third order neurons, 
remains largely intact even after significant photoreceptor cell loss. Santos et al., for 
example, reported that 80% of bipolar cells remained in the macular even at very late stages 
of RP (Santos et al., 1997). It is becoming clear that while these cells survive, they do 
undergo significant synaptic remodelling, a factor that must be borne in mind for replacement 
strategies [see section 6 and (Jones et al., 2003; Jones and Marc, 2005)]. Nonetheless, their 
continued survival and apparent synaptic plasticity presents the opportunity for replacing the 
lost photoreceptors. This might be by direct replacement with new healthy cells, or with other 
means of conferring light sensitivity, in the expectation that these remaining inner retinal 
neurons will be able to process this information and project it to the higher visual areas in the 
brain.  
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3. Novel Therapeutic Strategies for Retinal Repair 
 
The eye has several advantages over other CNS structures as a target for therapy 
development. These include its surgical accessibility, its simple and clearly understood 
anatomy, extensive understanding of both normal development and disease and its 
amenability to imaging and functional monitoring. Moreover, the eye is a paired structure and 
one that is relatively isolated from the rest of the body. This reduces the impact of any 
systemic adverse effects of treatment. It also allows for a relatively conservative treatment 
approach, even in the use of very novel treatments, as it is possible to treat one eye and 
spare the other.  
 
Strategies aimed at halting or delaying the loss of the diseased cells includes 
neuroprotection and the administration of anti-apoptotic and anti-inflammatory agents. Such 
strategies do not treat the underlying cause of the degeneration, but aim to slow disease 
progression and sustain sufficient useful vision throughout the lifetime of an affected 
individual. As noted above, recent advances in the treatment of wet AMD include the use of 
anti-angiogenic agents, such as VEGF inhibitors, which are now in routine clinical practice. 
These inhibitors block the actions of VEGF, which is considered to be largely responsible for 
the overgrowth of (leaky) blood vessels in the eye in the neovascular forms of AMD.  
 
Neurotrophic factors have been shown to have the potential to delay neuronal apoptosis. 
Neurotrophic factors are small proteins that have relatively short half-lives and a requirement 
for repeated administration has limited their clinical application to date. Since these proteins 
do not ordinarily cross the blood-brain barrier, previous approaches have relied upon 
intrathecal infusion pumps or similar complex devices to sustain elevated levels of these 
factors within the CNS. However, sustained delivery through viral vector mediated 
expression of genes encoding neurotrophic factors may circumvent the potential side effects 
of repeated administration [for review, see (Buch et al., 2007)]. These include the 
introduction of growth factors such as pigment epithelium derived factor (PEDF) and ciliary 
neurotrophic factor (CNTF) (Campochiaro, 2006; Leaver et al., 2006) and reports of 
sustained delivery of CNTF have been promising in terms of prolonging photoreceptor 
survival [See (Wen et al., 2012)]. Indeed, CNTF is surprisingly effective in rescuing retinal 
degeneration due to various causes, including mutations in genes expressed by 
photoreceptors or the RPE, as well as those induced by strong light, neurotoxins, or 
antibodies. However, corresponding improvements in visual function remain controversial 
(Rhee et al., 2013; Schlichtenbrede et al., 2003). Interestingly, stem cells have also been 
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used as a means of introducing neuroprotective growth factors into the eye. Wild type and 
genetically modified human neural progenitor cells survive for prolonged periods, secrete 
growth factors and rescue models of degeneration, including the Royal College of Surgeons 
(RCS) rat model of RP (Gamm et al., 2007). The mechanisms by which this protection 
occurs, however, remains unclear; the initial aim had been to test the cells as a continuous 
delivery system of glial cell line-derived neurotrophic factor (GDNF), although the wild type 
cells performed similarly well.  
 
Perhaps the most clinically advanced approach for inherited disorders is gene therapy, the 
use of viral vectors to reintroduce correct copies of the mutated gene into the diseased cells. 
This strategy offers the possibility of stopping disease progression, has proven very effective 
in a large number of animal models of inherited blindness and is now the subject of several 
clinical trials (Bainbridge et al., 2008; Jacobson et al., 2012; Maguire et al., 2008). A full 
description is beyond the scope of this review, and interested readers are encouraged to see 
the special edition of Gene Therapy, 2012 Feb; 19(2), including reviews by (Smith et al., 
2012) and an editorial by Ali R.R. (Ali, 2012).  Although effective, gene therapy requires a 
genetic diagnosis and for the cells carrying the mutation to be alive at the time of therapy, 
often necessitating early intervention. For this reason, and to enable the potential reversal of 
end stage disease, a variety of complementary approaches are being considered.  
 
An important feature in both animal models of RP and patients with RP or atrophic AMD, as 
mentioned above, is that despite the death of the overlying photoreceptor cells, much of the 
inner retinal neuronal architecture, including the ganglion cells, and the remaining visual 
pathway remain largely intact (Damiani et al., 2012; Mazzoni et al., 2008). Therefore, it may 
be possible to restore vision by either replacing the missing sensory cells, or by providing 
visual information to the remaining neurons of the retina, especially the ganglion cells. 
Strategies for late-stage retinal rescue include cell transplantation, electronic retinal 
implants, and optogenetic approaches. These latter strategies also do not interfere with the 
intrinsic progression of disease but attempt to restore photosensitivity by creating new 
photosensors and coupling them to the remaining retinal circuitry. Cell-based therapy 
encompasses both the reintroduction of healthy photoreceptors and/or RPE cells into the 
degenerating retina, as well as cellular regeneration, which involves the potential reactivation 
of dormant repair mechanisms within the retina itself, stimulating it to generate new 
photoreceptor cells. Very severe degeneration might be addressed by the transplantation of 
whole retinal sheets [reviewed in (Seiler and Aramant, 2012)] or the use of electronic 
devices, which directly stimulate the remaining ganglion cells [reviewed in (Stingl and 
Zrenner, 2013)]. A more recent and novel idea has been the use of optogenetics to replace 
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photoreceptor input by conferring light sensitivity to the remaining inner retinal neurons via 
the introduction of genetically encoded light sensitive proteins, using viral vectors [see 
review for further details (Busskamp et al., 2012)].  
 
In this review, we focus our attention on cell-based therapies, first providing a detailed 
overview of the mechanisms of endogenous retinal repair in vertebrates and the potential to 
reactivate such mechanisms following injury or the exogenous application of mitogens. 
Subsequently, we discuss the potential for replacing lost photoreceptors by transplantation 
together with recent advances in generating transplantation-competent donor cells from a 
variety of ocular and pluripotent stem cell sources.  
4. Retinal Development 
 
We begin with a broad description of the regulatory pathways involved in eye and retinal 
specification, with specific emphasis on photoreceptors. These provide a context within 
which to evaluate the protocols used for the generation of retina-specific cell types for 
transplantation purposes, as well as for strategies used to attempt to reactivate endogenous 
repair mechanisms. 
 
4.1. Eye Specification 
The eye is a highly specialised extension of the brain. In all vertebrates, eye development 
involves a series of complex interactions between the neural ectoderm, surface ectoderm, 
intervening mesoderm and the migrating neural crest cells. Consequently, it provides an 
accessible insight into neural development and represents an invaluable system for studying 
the interaction between cells of diverse origins. Shortly after gastrulation, a series of 
patterning events leads to a single patch of neuroepithelium within the midline of the anterior 
neural plate, the primordium of the forebrain, being specified to become of eye identity, 
termed the ‘eye field’. Separation of this single eye field laterally results in the formation of 
the optic primordia, which then evaginate to form the paired optic vesicles. Extension of 
these optic vesicles allows for contact with the overlying surface ectoderm. This area of 
contact develops to form the lens placode, and the primordia of other anterior structures 
such as the cornea and conjunctival epithelium. Simultaneous invagination of the optic 
vesicles results in the formation of two optic cups (Figure 2a). The inner layer of the optic 
cup develops into the neural retina and the non-pigmented region of the ciliary body (CB), 
while the outer layer acquires pigmentation and develops into the RPE and the pigmented 
region of the CB. The peripheral regions of the optic cup contain the progenitors that form 
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the auxiliary structures of the eye, the CB and iris. Notably, while the CB, iris and RPE are 
devoid of neurons and represent tissues both diverse in structure and function in the adult, 
they share a common origin with the multipotent neuroepithelium [reviewed in (Fuhrmann, 
2010)].  
 
While the formation of a functional eye requires the interaction between multiple embryonic 
tissues, the cellular origins of the neural retina can be exclusively traced to the neural 
ectoderm (Chow and Lang, 2001). Thus, the formation of the eye is tightly interconnected 
with the induction and patterning of the neuroepithelium at the onset of gastrulation. Studied 
by developmental biologists for centuries, one of the earliest stages in the establishment of 
neural tissue is the decision of ectodermal cells to adopt a neural fate at the expense of an 
epidermal lineage. At a general level, this is promoted by fibroblast growth factor (FGF) 
signals, and inhibited by transformation growth factor (TGF-β) and wingless (Wnt) signals. 
FGF signals are secreted prior to the onset of gastrulation and act to ‘prime’ the ectodermal 
cells to later respond to bone morphogenetic protein (BMP) signals, in the presence of low 
Wnt signals (Chang and Hemmati-Brivanlou, 1998; Hashimoto et al., 2000; Kazanskaya et 
al., 2000; Linker and Stern, 2004; Mukhopadhyay et al., 2001; Smith and Harland, 1991; 
Streit et al., 2000; Wolda et al., 1993). Subsequently, to establish and maintain a neural fate, 
ubiquitously expressed BMP signals must be repressed by antagonists, such as Chordin, 
Noggin, Follistatin and Cerberus, emanating from the neural organiser (the node in 
mammals) (Bouwmeester et al., 1996; Hemmati-Brivanlou et al., 1994; Niehrs, 2001). 
Notably, while FGF signals are required prior to BMP inhibition, this signalling pathway 
further represses BMP signalling in order to reinforce a neural fate (Rogers et al., 2009). 
Collectively, it is believed that ectodermal tissue primarily defaults to neural tissue with a 
forebrain character in the absence of instructive signals (Gamse and Sive, 2000; Houart et 
al., 1998; Houart et al., 2002; Paek et al., 2009) while posterior neural fates, such as that of 
the spinal cord, rely upon the presence of posteriorizing factors, including Wnts, FGFs and 
retinoic acid (RA), in addition to the inhibition of BMPs (Davidson et al., 2000; Durston et al., 
1989; Mason, 2007; Nordstrom et al., 2002) (Figure 2b).  
 
Following the establishment of forebrain tissue, rostro-caudal sub-patterning of this region is 
required to delineate the eye field from the telencephalon and diencephalon, and this 
process is largely dependent upon the graded expression of Wnts. For example, Zebrafish 
mutants of axin1, a scaffolding protein required for the down-regulation of Wnt signals, 
exhibit an expansion of the posterior diencephalic fate, at the expense of the more anterior 
eye and telencephalon (Heisenberg et al., 2001). Following the establishment of retinal 
identity, secreted factors emanating from the underlying axial mesoderm are required for the 
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separation of the single, centrally positioned eye field into two bilateral symmetrical retinal 
primordia. While historically believed to be dependent upon the expression of Sonic 
Hedgehog (Shh) signals from the underlying axial mesoderm, TGF-β and FGF signals are 
also required for this morphological event (Carl and Wittbrodt, 1999; England et al., 2006; 
Rebagliati et al., 1998; Varga et al., 1999).  
 
These extrinsic signalling molecules act in concert with intrinsic cell determinants to specify 
neural, and subsequently retinal identity. For example, formation of the neural plate from the 
definite ectoderm is marked by the upregulated expression of Sox1 (Pevny et al., 1998), and 
the expression of Gbx2 (Wassarman et al., 1997). Subsequently, neural progenitors 
contained within the neural tube can be characterised through the expression of several 
markers including, Sox1, Sox2, Nestin (Lendahl et al., 1990; Pevny et al., 1998; Wood and 
Episkopou, 1999), Musashi1 (Kaneko et al., 2000) and N-CAM (Ronn et al., 1998; 
Rutishauser, 1992). Similarly, retinal identity within the anterior neuroectoderm is achieved 
via the coordinated expression of several intrinsic determinants, termed the eye-field 
transcription factors (EFTFs) due to their ability to induce ectopic eye-like structures when 
mis-expressed in the frog embryo. These include Rax, Pax6, Lhx2, Six3, Optx2/Six6, 
ET/Tbx3, and tll/Nr2e1 and are expressed within the eye field with overlapping temporal and 
spatial expression patterns (Figure 3a) [reviewed in (Andreazzoli, 2009) and (Zuber et al., 
2003)]. These EFTFs also co-regulate each other. For instance, mis-expression of Pax6 
results in the activation of Six3, Lhx2, Tlx and Optx2, while overexpression of Six3 induces 
Pax6, Tll and Lhx2 (Zuber et al., 2003). Importantly, the molecular network of genes involved 
in eye formation is conserved between invertebrates and vertebrates, including humans, 
despite the considerable evolutionary distance and marked differences in eye anatomy and 
development between the groups (Wawersik and Maas, 2000). 
 
4.2. Retinogenesis 
Subsequent to eye field formation, the regionalisation of the optic vesicle and, later, the optic 
cup is reliant upon both extrinsic and intrinsic factors. From this stage, the cells contained 
within this neuroepithelial structure are known as retinal progenitor cells (RPCs), giving rise 
to both the neural retina and RPE. Studies in the developing chick have demonstrated that 
high levels of FGF signalling, derived from the overlying surface ectoderm, are required for 
the induction of the neural retina tissue from the neuroepithelium; FGF signalling represses 
the RPE-specific basic helix-loop-helix transcription factor, Mitf, which is required for the 
acquisition and preservation of RPE fate (Nguyen and Arnheiter, 2000). Repression of Mitf 
allows for the expression of the paired-like homeodomain transcription factor Vsx2 (formerly 
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Chx10), which marks the onset of neural retinal development within the optic vesicle, and as 
such, this factor is regarded as the earliest retinal specific marker (Figure 3a). This factor is 
expressed within all RPCs, subsequently becoming restricted solely to the post-mitotic 
bipolar cells and a subset of Müller glia cells within the postnatal retina. Inactivation of this 
gene in mice demonstrates that it is crucial for the proliferation of RPCs, especially within the 
peripheral retina (Bone-Larson et al., 2000; Burmeister et al., 1996). It is important to note 
that following the formation of these two distinct layers of the optic cup a high degree of 
plasticity still exists. The RPCs within the presumptive neural retina retain the potential to 
generate RPE cells (Horsford et al., 2005; Rowan et al., 2004). Additionally, the RPE 
monolayer is able to differentiate into retinal neurons (Opas et al., 2001; Reh and Pittack, 
1995; Stroeva and Mitashov, 1983).  
 
Retinogenesis is highly conserved within vertebrates. Invariably, the first cell type to emerge 
in all vertebrates is the ganglion cell, followed in partially overlapping phases by horizontal 
cells, cone photoreceptors and amacrine cells, while the rod photoreceptors, bipolar 
interneurons and Müller glia cells appear last (Marquardt, 2003; Marquardt and Gruss, 
2002). Based upon seminal cell lineage studies, RPCs contained within the developing optic 
cup have been shown to be inherently multipotent, with a single progenitor cell competent to 
give rise to all retinal neuron and glia cell types (Holt et al., 1988; Turner et al., 1990; Turner 
and Cepko, 1987). These findings are encompassed in the competence model of retinal 
histogenesis, which hypothesises that RPCs undergo a unidirectional change in their 
competence to generate the different cell types of the mature retina (Cepko et al., 1996). 
 
RPCs are required to undergo several rounds of division to generate a robust pool of 
progenitors, prior to exiting the cell cycle and differentiating into the retinal cell types. Several 
growth factors employed during the patterning of the neural tube and eye have been shown 
to additionally participate in the acceleration and maintenance of this progenitor pool. Much 
of this work has come from in vitro studies on retinal explants, which have demonstrated that 
the addition of growth factors, including Shh, FGFs and epithelial growth factor (EGF), to 
retinal explants in culture is sufficient to increase proliferation (Figure 2b) (Anchan et al., 
1991; Jensen and Wallace, 1997; Levine et al., 1997a; Lillien, 1995; Lillien and Cepko, 
1992). Supporting these studies, expression analyses have confirmed the presence of these 
factors from either within the retina or RPE during the period of cell expansion in the 
developing retina (Chen et al., 2013; Levine et al., 1997a; Lillien, 1995). The responsiveness 
of the developing retina to such factors has been shown to change over time. For example, it 
has been shown that earlier progenitor cells preferentially respond to FGF signals, whilst 
later progenitors are more sensitive to changes in EGF (James et al., 2004; Lillien, 1995). In 
 12 
line with the competency model mentioned above, it is believed that gradual changes in 
intrinsic and extrinsic determinants shift the competence of RPCs to generate all retinal 
subtypes. Important cell determinants include the basic helix-loop-helix (bHLH)- and 
homeobox-type transcription factors, which co-ordinate to contribute to the intrinsic 
properties of retinal precursors, further influencing the determination and differentiation of 
multiple cell types. While a large number of intrinsic factors have been identified, the full 
repertoire remains to be established (Cepko, 2014).  
4.2.1. From RPCs Towards a Photoreceptor Cell Fate 
 
Photoreceptors are born over a long temporal period, which in the mouse spans from 
embryonic day  (E) 12 to postnatal day (P) 10 (Carter-Dawson and LaVail, 1979b; Morrow et 
al., 1998; Rapaport et al., 2004; Young, 1985). Following the last mitotic division of a RPC 
committed to generate a photoreceptor cell, these precursors can take up to two weeks after 
birth to mature and form outer segments. Cone photoreceptors are born first, as early as 
E11 in the mouse, and their genesis is complete by birth. The mouse has two types of cone 
opsin, conferring dichromatic colour vision: S opsin (blue-sensitive opsin), which starts to be 
expressed at E18; and M opsin (green-sensitive opsin), which is expressed later in 
development at P6. Conversely, rod photoreceptors are generated over a longer period of 
time compared to cones, starting at embryonic stage E12 and continuing until P10, peaking 
at P0. Rod photoreceptors contain only one rod-specific visual pigment, Rhodopsin, which 
starts to be expressed after birth at P2. As photoreceptors mature, the expression levels of 
opsins increase substantially, outer segments mature and synaptic connections form with 
horizontal and bipolar interneurons [reviewed in (Swaroop et al., 2010)].  
 
The development of photoreceptor cells can be broadly categorised into several stages, 
including (1) proliferation of RPCs to generate sufficient numbers of cells required for a 
functional retina; (2) restriction in the competence of these RPCs to generate all cell types of 
the retina; (3) cell fate specification and commitment towards a photoreceptor cell fate; (4) 
maturation of rods and cone photoreceptors, including the expression of photoreceptor-
specific genes essential for function of these specialised cells, and the formation of outer 
segments and synaptic connections (Figure 3).  
 
Once again, the interplay between both intrinsic determinants and extrinsic factors is 
required for the correct specification and maturation of these specialised cell types. One of 
the earliest stages in photoreceptor development relies upon signalling through the Notch 
receptor (Jadhav et al., 2006; Yaron et al., 2006). High concentrations of Notch allow for the 
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maintenance of cycling progenitors, through down-regulating the expression of proneural 
genes, including NeuroD1, Neurogenin2, Math3, Math5 and Ascl1 (Hatakeyama and 
Kageyama, 2004; Le et al., 2006). Conversely, inhibition of Notch leads to the production of 
cone photoreceptors during earlier development and rod photoreceptors at later stages 
(Yaron et al., 2006). In addition, other signalling molecules including Shh can also influence 
progenitor commitment through converging downstream Notch targets (Wall et al., 2009). 
Currently, the molecular mechanisms that underlie the generation of photoreceptor 
precursors from RPCs, including the down-regulation of Notch signalling, remain to be 
elucidated.   
 
We have a better understanding of the subsequent events that drive a photoreceptor 
precursor towards a rod or cone fate. Several transcription regulators central to this process 
have been identified. These can be regarded as photoreceptor transcription factors, as they 
are preferentially expressed by either immature post-mitotic photoreceptor precursors, 
and/or mature photoreceptors (Figure 3b).  Over the past years, efforts have been focused 
on characterising the roles of these photoreceptor transcription factors in an attempt to better 
understand the development of these specialised neurons, and their role in disease. Our 
knowledge to date is briefly outlined below. For a more in-depth knowledge of this process, 
the reader is directly to excellent reviews by (Cepko, 2014; Cepko, 1999; Hennig et al., 
2008; Swaroop et al., 2010). 
 
The onset of specification of a precursor cell towards a photoreceptor lineage begins with 
the expression of two key transcription factors, Otx2 and Crx. Otx2 belongs to the paired-like 
homeodomain transcription factors and is expressed in RPCs undergoing their final mitotic 
division and in early precursors committed to a photoreceptor cell fate. Conditional knockout 
of Otx2, where Otx2 is inactivated under the control of the Crx promoter, leads to the near-
complete loss of photoreceptor cells in mice, converting photoreceptors to amacrine-like 
cells (Koike et al., 2007; Nishida et al., 2003), while retroviral gene transfer of Otx2 directs 
RPCs towards a photoreceptor fate (Nishida et al., 2003). Otx2 directly activates the 
expression of another member of the Otx homeobox gene family, the Cone-Rod homeobox 
transcription factor, Crx, in order to cement a photoreceptor fate (Nishida et al., 2003). Crx 
expression is first detectable in early post-mitotic rod and cone photoreceptor precursors and 
it is essential for the differentiation, maturation and maintenance of photoreceptors; loss of 
Crx in mice does not prevent the production of photoreceptor cells, however maturation of 
these cells fails to occur, resulting in the lack of outer segment, and eventually, retinal 
degeneration (Furukawa et al., 1999). While these two transcription factors are sufficient to 
induce a photoreceptor fate, it is likely that other transcription factors, including the PR-
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domain zinc finger protein 1 (also known as BLIMP1), are required to stabilise the 
commitment of Otx2-expressing cells towards this lineage (Brzezinski et al., 2010; Katoh et 
al., 2010). 
 
Following commitment to a photoreceptor cell fate, additional transcription factors are 
required to promote the generation of either rod or cone photoreceptors. Of key importance 
in this fate is the transcription, Nrl. Nrl is a basic motif leucine zipper transcription factor that 
is preferentially expressed in rod photoreceptor precursor cells shortly after terminal mitosis, 
and as such, it is regarded as one of the earliest rod-specific photoreceptor markers 
(Akimoto et al., 2006). Loss of Nrl results in the loss of rod photoreceptors and an excess of 
cone-like photoreceptors (Mears et al., 2001a). Nrl acts in multiple ways to promote a rod 
lineage, including acting synergistically with Crx to activate the Rhodopsin promoter. It also 
directly activates Nr2e3, which functions to both promote rod photoreceptor genesis and 
concomitantly repress cone-specific genes (Oh et al., 2008). The peak expression of this 
transcription factor coincides with rod photoreceptor differentiation, with a subsequent 
decline in expression during adult stages, however expression is maintained in mature rod 
photoreceptors, suggesting that it is required for both rod maintenance as well as 
differentiation (Chen et al., 2005; Peng et al., 2005).  
 
While the commitment towards a cone photoreceptor is less clear than that of a rod fate, 
several genes have been implicated in this process. The retinoid-related orphan receptor 
Rorβ synergises with Crx to positively regulate the cone S-opsin gene in vitro (Srinivas et al., 
2006a). Surprisingly, in vivo knockdown of this receptor results in the loss of rod 
photoreceptor cells and an excess of S-opsin cone photoreceptors, similar to that seen in the 
Nrl-/- mouse (Mears et al., 2001b). Subsequently, it has been shown that loss of this receptor 
leads to the absence of Nrl, suggesting that Rorβ2 lies upstream of Nrl (Jia et al., 2009). 
Additionally, it has been shown that Rorβ acts synergistically with Crx to initiate S-opsin 
transcription in cones (Srinivas et al., 2006b). Despite the increase in S-opsin cones in the 
Rorb-/- mouse, these cells are non-functional, and more primitive than those in Nrl-/- mice. In 
keeping, Rorβ has been shown to be required for the formation of photoreceptor outer 
segments, contributing to the development of the inner retina and synaptic layers of the 
retina (Jia et al., 2009).  
 
The receptors, Rxrγ and Trβ2, are also required for cone photoreceptor identity. The Rxrγ 
receptor is detectable within differentiating cone photoreceptors as well as ganglion cells. In 
mice, Rxrγ receptor knockout results in the loss of the ventral-dorsal distribution gradient of 
S cones and instead results in S-opsin-expressing cones throughout the retina, suggesting 
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that Rxrγ acts in an inhibitory manner to restrict S-opsin expression (Roberts et al., 2005). 
Separately, the nuclear receptor Trβ2 responds to increasing levels of circulating thyroid 
hormone during development to direct the differentiation of cone photoreceptors. 
Specifically, deletion of Trβ2 causes an increase of S-opsin cones at the expense of the M-
opsin subtype (Ng et al., 2001a; Swaroop et al., 2010).    
 
In addition to their roles in early eye development, several secreted factors have been 
shown to play an important role in the specification and differentiation of the different classes 
of retinal cell types. Shh, FGF2, taurine, activin and RA have been all been reported to 
promote the maturation of rod photoreceptors; exogenous application of these molecules to 
cultured retinal explants results in an increase in the Rhodopsin-positive cell population 
(Davis et al., 2000; Hicks and Courtois, 1988; Hicks and Courtois, 1992; Hyatt and Dowling, 
1997; Levine et al., 1997b; Young and Cepko, 2004). While less is known about the extrinsic 
factors important to cone photoreceptor genesis, inhibition of RA in zebrafish has been 
shown to promote cone neurogenesis (Hyatt et al., 1996) and, as mentioned above, thyroid 
hormone signalling plays a central role in cone opsin expression and patterning in the retina 
(Ng et al., 2001b; Roberts et al., 2006).  
  
4.3. Human Retinal Development 
In comparison to our knowledge of retinal development in lower vertebrates, our 
understanding of human eye development is far more limited. Classical studies have 
described the morphological structures of the human embryonic and fetal eye using light 
(Hollenberg and Spira, 1973; Man et al., 1964; O'Rahilly, 1975; O'Rahilly et al., 1982; 
Rhodes, 1979) and electron (Hollenberg and Spira, 1973) microscopy. These studies 
document the timing and morphological changes involved in the formation of the optic 
vesicles, optic cups and the process of retinogenesis.  
 
Unlike the rodent retina, which has three types of photoreceptor cells (rods and S- and M-
opsin cones), the human retina contains four types of photoreceptor cells; the rod and three 
types of cones (S, L, and M cones) (Nathans et al., 1986). The expression pattern of human 
proteins during fetal retinogenesis has been described and similar molecular players 
involved in the development and specification of photoreceptors in lower vertebrates and 
mammals are also present in the human eye (Hendrickson et al., 2008). Furthermore, the 
temporal appearance of these markers appears to be conserved. NRL and NR2E3 positive 
rod cells are detected as early as fetal week 10.5-11 followed by RECOVERIN and 
interphotoreceptor retinoid binding protein (IRBP) at 12 fetal weeks, and finally components 
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of the phototransduction cascade, including RHODOPSIN, PERIPHERIN and ROD 
ARRESTIN, at 14 fetal weeks (Hendrickson et al., 2008). Much of our understanding of the 
role of specific transcription factors in human development has been inferred from clinical 
phenotypes. Heterozygous mutations of OTX2 cause severe ocular malformations (Ragge et 
al., 2005), while mutations in CRX and NRL have been implicated in Leber’s congenital 
amaurosis (LCA) (Freund et al., 1998; Ragge et al., 2005; Rivolta et al., 2001), cone-rod 
dystrophies (Freund et al., 1997), RP (Sohocki et al., 2001) and clumped pigmentary 
degeneration (Nishiguchi et al., 2004). Human genetic studies have, in turn, informed studies 
in lower vertebrates and animal models, and together have aided the progress of our 
understanding of both eye development and regenerative processes. Later in the review we 
describe the advent of mouse and human differentiation cultures from mouse and human 
embryonic stem cells (ESCs). These open up a whole area of research into human retinal 
development in vitro.  
5. Lessons from Lower Vertebrates: Endogenous Retinal Repair Mechanisms 
 
As noted above, current strategies for addressing retinal degeneration are limited to slowing 
disease progression. One very attractive strategy to reverse the cellular loss is to encourage 
the retina to repair itself. In the mammalian retina, retinogenesis is completed during 
development and no neurons are added once the animal has reached maturity. By contrast, 
classical studies in lower vertebrates have shown that neurogenesis continues through their 
lifetime. Moreover, they are capable of repairing their retinae following injury, typically via 
populations of stem cells located in a variety of structures within the eye. Many repair 
mechanisms are conserved, not only between development and adult regeneration, but also 
over the course of evolution. For this reason, the study of retinal regeneration in lower 
vertebrate animals has provided important insights into the potential for retina regeneration 
in adult mammalian animals, including humans. Indeed, our increasing understanding of 
these mechanisms has not only permitted the development of protocols for the stepwise 
differentiation of ocular and pluripotent stem cells for transplantation purposes (see sections 
7 & 8), but also raises the prospect of reactivating these mechanisms in the otherwise 
quiescent mammalian retina. Classically, three categories of model animals have dominated 
the field of regeneration; 1) amphibians and fish, which can naturally regenerate after retinal 
damage; 2) the postnatal chick, which shows a restricted potential for retinal regeneration 
compared to fish and amphibians; and 3) rodents, which normally do not regenerate 
following retinal damage, but represent an important model that can allow for new strategies 
for mammalian retinal repair to be devised and evaluated. In the next section, regions of 
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continued retinogenesis within the normal adult eye will be discussed, as well as activation 
of cells following injury and stimulation with exogenous growth factors. 
 
During development, growth factors influence a variety of cellular processes, including the 
proliferation, migration and differentiation of stem- and progenitor- cells (Loughlin and Fallon, 
1993). Significantly, following injury, many cells can either re-express growth factor receptors 
in order to respond to local growth factors, or upregulate the expression and release of 
various growth factors, which can leads to increases in proliferation, migration and 
differentiation. Of note, the type of injury can play a part in determining which growth factor 
pathways are activated and, ultimately, the cellular response initiated. Taken together, 
studies to date have mainly focused on stimulating endogenous stem cell-like cells by 
intraocular administration of relevant mitogenic factors, in order to reactivate this population.  
   
5.1. Retinal Repair by the Vertebrate CMZ and CB 
5.1.1. The CMZ in Lower Vertebrates 
 
Birthdating studies in fish and amphibians have demonstrated that new neurons are 
continually added to the retina in concentric rings. These neurons arise from stem cells 
located at the peripheral region of the retina, termed the Ciliary Marginal Zone (CMZ) (Johns 
and Easter, Jr., 1977; Straznicky and Gaze, 1971). In a recapitulation of embryonic 
retinogenesis, cells situated at the peripheral edge of the retina are younger than their more 
centrally located counterparts. A population of multipotent retinal stem cells residing in the 
outermost tip of the CMZ express the EFTFs rx1 (the amphibian homolog of Rax1), six3 and 
pax6 (Perron et al., 1998). Of note, while retinogenesis continues throughout life, the 
regeneration potential of the CMZ cells declines with age [Reviewed in (Amato et al., 2004; 
Harris and Perron, 1998; Locker et al., 2009; Locker et al., 2010; Moshiri et al., 2004; Perron 
and Harris, 2000)].  
 
While acting mainly to facilitate the increasing body growth, retinogenesis also allows for 
cellular repair after injury. The plasticity of the stem cells within the CMZ has been 
demonstrated following the ablation of particular cell types. For instance, selective 
destruction of dopaminergic amacrine cells by neurotoxin administration into the eyes of 
Rana results in the production of this specific cell type by stem cells within the CMZ (Reh 
and Tully, 1986). Similarly, kainic acid-induced loss of glutaminergic cells stimulates the 
production of new glutaminergic cells (Reh, 1987). It should be noted however, that despite 
the common neuroepithelial origin of the neural retina and RPE, these adult retinal stem 
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cells are restricted in fate solely to produce retinal cell types, and do not contribute to RPE. 
Instead, both tissues have been shown to harbour independent tissue-specific stem cells to 
accommodate any changes through their post-embryonic life (Centanin et al., 2011). With 
regards to retinal injury, these CMZ cells are also responsive to the exogenous application of 
growth factors. Within the fish eye, growth hormone and insulin growth factor-1 (IGF-1) have 
been shown to regulate neurogenesis, increasing the mitotic index of CMZ stem 
cells/progenitors (Otteson et al., 2002).  
 
More recently, research groups have focused their attention on attempting to characterise 
the CMZ of lower vertebrates, including the identification of candidate genes and signalling 
pathways involved in the maintenance of this niche (El et al., 2012; Parain et al., 2012). For 
instance, Parain and colleagues recently conducted a large scale screening to gain insights 
into the molecular signature of retinal stem cells within the CMZ of post-embryonic Xenopus 
tadpoles, revealing 18 novel genes not previously associated with the CMZ (Parain et al., 
2012). As might be anticipated, many of the key players involved in embryonic retinal 
development are also important in the maintenance of the CMZ in the adult. Denayer and 
colleagues were able to demonstrate that the canonical Wnt signalling pathway is active 
within the post-embryonic Xenopus tadpole CMZ, and is required for the proliferation of 
these cells in vivo without affecting the differentiated cells of the retina (Denayer et al., 
2008a; Denayer et al., 2008b), a finding that is also supported by data derived from the fish 
(Borday et al., 2012; Meyers et al., 2012). Similarly, hedgehog (Hh) signalling has also been 
shown to regulate the activity of the CMZ, by directly antagonising the canonical Wnt 
pathway (Borday et al., 2012). For more in-depth information on lower vertebrate retinal 
regeneration, the reader is directed to the following reviews [(Amato et al., 2004; Locker et 
al., 2009; Locker et al., 2010; Moshiri et al., 2004; Perron and Harris, 2000)]. 
 
5.1.2. The CB and Peripheral Retina in Mammals 
 
In 2000, Fischer and Reh reported a proliferative zone at the peripheral edge of the retina in 
chickens and quails, potentially analogous to the lower vertebrate CMZ (Fischer and Reh, 
2000; Kubota et al., 2002). This proliferative region persists for up to three months post-
hatching. Following the identification of this CMZ-like region in the chick, it was hypothesised 
that similar regions may exist in other warm-blooded vertebrates. In contrast to the mouse 
where retinal histogenesis is complete by P11, the eyes of the marsupial opossum undergo 
a significant amount of maturation post-birth. In a comparative study of these two animals, 
Kubota and colleagues found that the opossum, but not the mouse, contains a small 
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population of CMZ-like cells at the proliferative margin of the retina (Kubota et al., 2002). 
Intriguingly, subsequent studies have revealed the presence of a few quiescent retinal 
stem/progenitor cells that persist at the peripheral margin of the murine retina during early 
postnatal stages; BrdU-positive cells are still detectable in the anterior margin of the retina 
until P14 (Abdouh and Bernier, 2006; Moshiri and Reh, 2004; Zhao et al., 2005). Likewise, a 
developmental study comparing the proliferative potential of dissociated cells isolated from 
different stages of the postnatal rat retina demonstrated that cells isolated from early 
postnatal retinas (P1-3) can be clonally expanded in vitro, while cells isolated from P8 
retinas have a lower proliferation potential and this property is wholly absent by P14 
(Engelhardt et al., 2004). In agreement, we, and others, have shown that dissociated adult 
retinae (from three-four weeks onwards) fail to give rise to neurospheres in vitro (Ahmad et 
al., 2000; Kokkinopoulos et al., 2008).  
 
Although endogenous proliferation disappears in the adult mammalian retina, studies have 
demonstrated that cells at the peripheral margin can be coaxed into maintaining their 
proliferative state either by the ectopic activation of signalling pathways or in response to 
disease. Intravitreal injections of insulin and FGF2 induced proliferation of these cells in P14 
and P21 rats (Zhao et al., 2005). Consistent with the progressive reduction of the number of 
retinal stem/progenitor cells with age, this growth factor-mediated response is time-
dependent, as the same growth factors did not induce proliferation in adult rats (P56-59) 
(Abdouh and Bernier, 2006). Importantly, and of potential clinical value, a residual population 
of CMZ-like cells has also been reported within the peripheral region of primate eyes. 
Martinez-Naverrete et al. demonstrated that a population of NESTIN and PCNA-positive 
cells exist within the young adult macaque (ages five-six years) and mature human (aged 
between 45-60 years) (Martinez-Navarrete et al., 2008). Potentially describing the same 
population, Bhatia et al. examined the effect of culturing human cadaveric eyes in the 
presence of EGF and observed a significant increase in the expression of the proliferation 
marker Ki67 in the non-laminated, most anterior region of the retina, when compared to 
retinae cultured without growth factor supplementation (Bhatia et al., 2009).  
 
A number of studies have sought to determine whether stem cell-like cells at the periphery 
attempt to repair the diseased retina. In ptc+/- mutant mice, which have constitutively 
activated Shh signalling, proliferating cells can be detected within the retinal margin up to 
three months postnatally (the latest time point analysed). Furthermore, when crossed to a 
pro23his degenerative background, the numbers of proliferating cells are additionally 
increased, with the retinal margin of the ptc+/-; pro23his mouse having more than a 50% 
increase in BrdU-positive cells when compared to ptc+/- animals. These persistent 
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progenitors attempt regeneration through the production of photoreceptor cells, albeit to a 
limited extent (Moshiri and Reh, 2004). In the RCS rat model, BrdU-positive and Vsx2-
positive cells are also significantly increased in the peripheral marginal zone during stages 
equivalent to mid-stage (P30) and later stage (P60) disease progression when compared 
with age-matched Long Evans control rats. This appears to be related to the upregulation of 
Shh pathway, as mRNA levels for Shh, Ptc1 and Smo are increased in the P30 RCS rats 
compared with controls. In contrast to the previous study though, the increased proliferation 
does not appear to result in the generation of new retinal neurons (Jian et al., 2009). In 
addition to the cells in the peripheral margins of the neural retina, a number of groups have 
documented the presence of cells with proliferative potential within the CB itself. This has 
generated much interest for many reasons. Firstly, despite being both anatomically and 
functionally distinct from the neural retina, it is located immediately adjacent and in a 
continuum with the neural retina, in a region potentially accessible via routine surgical 
approaches. This has led to interest in these cells as a potential source of patient-derived 
donor cells for transplantation purposes. Secondly, while no neurons are contained within 
this region of the eye, the CB is also a derivative of the neural ectoderm, indicating that it 
could be a potential source for endogenous neural regeneration and repair in higher 
vertebrates. Within the CB lies a bi-layered epithelium termed the CE. The inner layer of this 
epithelium is transparent, and is continuous with the neural retina and the iris. In contrast, 
the outer layer is pigmented and lies between the RPE and the root of the iris (Figure 1a) 
(Davis et al., 2009).  
 
Despite being quiescent in vivo, two independent groups reported that a population of cells 
within the rodent CE displayed properties of stem cells in vitro, when dissociated and grown 
in culture [see section 7.1.1; (Ahmad et al., 2000; Tropepe et al., 2000)]. These cells can be 
also reactivated in vivo in response to intra-ocular injections of FGF2 and insulin (Abdouh 
and Bernier, 2006; Zhao et al., 2005). However, although these cells co-express Nestin and 
either Pax6 or Vsx2, implying a commitment towards a retinal lineage, none were capable of 
differentiating into retinal neurons or migrating into regions of the neural retina (Abdouh and 
Bernier, 2006). In addition to growth factor-mediated stimulation, a recent study has 
demonstrated that inactivation of the Rho family of signalling proteins results in increased 
proliferation of adult CE cells in situ, an effect that can be augmented when combined with 
exogenous growth factors (Del Debbio et al., 2014). Likewise, treatment with paroxetine, a 
selective serotonin reuptake inhibitor commonly used for depressive disorders, results in 
increased proliferation of this population in vivo (Wang et al., 2010). These studies also 
report co-expression of Pax6, Vsx2 and Nestin. Markers of a more differentiated phenotype 
were not assessed (Del Debbio et al., 2014; Wang et al., 2010). 
 21 
 
Reports have also suggested that the stem cell-like cells within the CE can be reactivated 
following injury. Two independent studies have followed the effects of lesion-induced 
injuries, either optic nerve transection (axotomy) or optic nerve-crush, on the proliferation of 
these latent CB stem/progenitor cells in vivo. In the first study conducted in adult mice, 
Nickerson and colleagues analysed the effects of axotomy on CB stem/progenitors, using 
the expression of Nestin as a marker for early neural stem/progenitor cells (Nickerson et al., 
2007). They described two separate populations of Nestin-positive progenitors within the 
naïve CB. One population corresponded to pericytes, but the second population was found 
within the CE. In response to axotomy, these CE-located cells began to proliferate and 
upregulate the expression of the retinal progenitor marker, Vsx2, although they failed to 
express Mushashi-1 and Pax6, two additional markers of retinal stem/progenitor cell. In 
support of this study, Wohl et al. also observed an increase in the number of proliferating 
cells in the CB of adult mice following both ON lesion and crush. Under both injury 
conditions, similar numbers of Nestin-positive/ BrdU-positive cells were observed, 
suggesting the activation of the same cell population (Nickerson et al., 2007; Wohl et al., 
2009). However, as with those generated following growth factor-mediated stimulation, the 
proliferative cells are restricted to the CE, and they and their progeny do not extend to the 
adjacent retina, suggesting an inability to migrate (Nickerson et al., 2007). Interestingly, 
these cells do appear to have the potential to generate new photoreceptor precursors; 
Nishiguchi et al. reported an increase in Recoverin-positive cells within the CE, when 
compared with untreated control animals, following N-methyl-N-nitrosourea (MNU) induced 
neurotoxic injury (Nishiguchi et al., 2008). However, these cells did not mature, instead 
remaining morphologically reminiscent of P4 photoreceptor precursors within the developing 
retina. They were also small in number, suggesting that their ultimate contribution to retinal 
function might be limited (Nishiguchi et al., 2008).  
 
Collectively, these reports suggest that the mammalian CE and the peripheral retina contain 
stem/progenitor-like cells that are amenable to extrinsic stimulation and can undergo limited 
proliferation and differentiation towards a retinal neuronal fate. However, to date, very few 
reports have found markers of mature retinal neurons within the cells produced by the CB of 
adult animals. Moreover, the newly generated cells do not appear to migrate away from the 
confines of the CB. These cells may either lack the intrinsic capability of differentiating 
further along retinal lineages, or additional inhibitory cues may exist within their 
microenvironment to inhibit further migration and/or differentiation. Until we have greater 
understanding of this niche, these cells represent an intriguing but challenging source for 
widespread retinal repair of the human retina.  
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5.2. Retinal Repair by RPE  
 
Located between the retina and the choroid, the RPE in the mature eye is a highly 
pigmented monolayer of epithelial cells that, under normal conditions, are post-mitotic. 
Similar to the retina, this structure is a derivative of the neural ectoderm (see section 4.1) but 
neurogenesis is suppressed upon acquisition of the pigmented phenotype (Gallina et al., 
2013).  
5.2.1. RPE in Lower Vertebrates 
 
Retinal regeneration in amphibians occurs predominantly via RPE transdifferentiation. In 
salamanders and tadpole frogs, acute injury to the retina stimulates the cells of the RPE to 
de-differentiate and proliferate to become retinal neurogenic precursors. This process of 
retinal regeneration from RPE cells has been documented to occur at all stages of 
development, from early embryonic stages to post-metamorphic stages. Notably, as this 
process of transdifferentiation occurs, the RPE is replenished as the new retina is formed 
[reviewed in (Barbosa-Sabanero et al., 2012)]. It is thought that the process of retinal 
regeneration in these animals is largely regulated by inductive signals released by the 
extracellular matrix (ECM) (Reh et al., 1987). Indeed, exogenous application of FGF2 is 
sufficient to stimulate the regenerative properties in the Xenopus laevis stage 51-54 tadpoles 
following a retinectomy that leaves only the RPE intact (Ueda et al., 2012).The adult newt is 
capable of regenerating the retina without any extrinsic stimulation and does so by 
transdifferentiation of RPE cells, with a smaller contribution from the CMZ. To date, the 
molecular mechanisms underlying these processes remain to be determined; however, gene 
profiling analyses have demonstrated that the classic retinal stem/progenitor cell markers, 
including pax6, vsx2, mushashi-1 and notch, are involved [reviewed in (Barbosa-Sabanero 
et al., 2012)]. In addition to these intrinsic factors, pharmacological application of a Notch 
inhibitor during transdifferentiation results in premature neural differentiation, implicating the 
Notch pathway in RPC maintenance and inhibition of retinal differentiation (Nakamura and 
Chiba, 2007). Finally, more recent studies have shown that in addition to Notch and FGF 
signalling, cell cycle entry is mediated by heparin, which results in the activation of the Wnt, 
Shh and thrombin pathways (Yoshikawa et al., 2012).   
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5.2.2. RPE in Mammals 
 
The embryonic RPE in rats has been shown to possess the ability to regenerate retina via 
transdifferentiation; this capacity is very restricted, however, being solely confined to 
embryonic stages (Zhao et al., 2001). Interestingly, during development, proliferation in the 
immature, undifferentiated RPE is higher than in older, pigmented RPE due to the absence 
of L-dopa, a key cell cycle regulator and an upstream element in melanin synthesis (Ilia and 
Jeffery, 1999; Kralj-Hans et al., 2006). This indicates that the capacity for transdifferentiation 
in the mammalian eye is lost following establishment of the RPE pigmented phenotype. 
Nonetheless, a proliferative cell population within the peripheral region of the mature RPE 
has been identified in both human and rat RPE tissue, assessed by the presence of Ki67-, 
PCNA- and BrdU-positive cells (Al-Hussaini et al., 2008). As noted for similar proliferative 
cells in the CE, the numbers decline with age from around 20-30 cells per retina at two 
months of age, to just 8-10 by 1 year. In this study, no markers of neuronal differentiation 
were assessed. Consequently, while these cells represent a proliferative population of cells 
within the peripheral region of the retina, whether they can contribute to repair remains to be 
determined.  
5.3. Retinal Repair by the Iris in Lower Vertebrates 
 
The iris pigmented epithelium (IPE) is composed of two cell monolayers: the posterior and 
anterior IPE. The posterior IPE cells are heavily pigmented and are derived from the neural 
ectoderm, similar to the neural retina, RPE and CB. Under normal conditions, this structure 
is devoid of neural cells and possesses no potential for generating neurons (Arnhold et al., 
2004; Freddo, 1996). The IPE cells of the newt are able to regenerate eye tissue, but only 
that of the lens. When dorsal pigmented iris epithelium is placed into a regenerating limb, 
this tissue still results in the formation of a lens. Thus, it is believed that the regenerative 
potential of the dorsal iris tissue is restricted and unipotent [see (Tanaka and Reddien, 2011) 
and (Tsonis and Del Rio-Tsonis, 2004) for review]. To date, no reports of mammalian IPE-
derived regeneration in vivo have been documented.  
5.4. Retinal Repair by Müller Glia 
 
In the normal healthy retina, Müller cells constitute the principal glia type, adopting many of 
the functions carried out by the astrocytes and oligodendrocytes in the brain. Present in all 
vertebrate species, Müller cells are radial glia cells that span the entire depth of the retina 
with their soma contained within the inner nuclear layer (INL) of the retina [Reviewed in 
 24 
(Bringmann et al., 2006; Gallina et al., 2013; Lenkowski and Raymond, 2014; Newman and 
Reichenbach, 1996)]. While retinal neurons are highly susceptible to various forms of injury, 
Müller glia cells are exceptionally resistant to ischemia, anoxia and hypoglycaemia, a feature 
attributed to their particular type of energy metabolism (Silver et al., 1997; Stone et al., 
1999). Thus, Müller cells can survive most retinal injuries, acting as a key population of cells 
available during pathogenic situations. This makes them particularly attractive as targets for 
regenerative strategies. Below, we discuss some of the key findings regarding Müller glia-
mediated repair in both lower vertebrates and the mammalian retina, but direct interested 
readers to the excellent and comprehensive review by (Goldman, 2014).  
5.4.1. Müller Glia in the Fish 
 
In notable contrast to amphibians (see section 5.2.1), retinal regeneration and repair in fish 
is achieved by Müller glial cell proliferation. Upon activation, these cells proliferate, albeit for 
a limited number of divisions, whereupon the progeny subsequently migrate from the INL to 
the outer nuclear layer (ONL) and differentiate into rod photoreceptors. Using a transgenic 
zebrafish with a glial-specific promoter (glial fibrillary acidic protein (GFAP)) driving green 
fluorescent protein (GFP) in differentiated Müller glia cells, Bernardos and colleagues 
demonstrated that, in fish, Müller glia cells express low levels of the retinal progenitor marker 
pax6, and proliferate at low frequencies within the mature, intact retina. These progenitor 
cells express the cone/rod specific transcription factor, crx, allowing for the generation of rod 
photoreceptors post-embryonically (Bernardos et al., 2007). This study supports previous 
work by Fausett and Goldman, who used isolated fragments from the goldfish -1 tubulin 
gene promoter, which specifically drives GFP expression in Müller glia cells, and 
demonstrated the appearance of GFP-positive neurogenic clusters following stab wound 
injury (Fausett and Goldman, 2006).  
 
Interestingly, the key transcription factors sufficient for somatic cell re-programming (the so-
called Yamanaka factors, see (Takahashi and Yamanaka, 2006)), c-myc, nanog, sox2 and 
oct4, are upregulated by Müller glia in regenerating zebrafish retina following injury 
(Ramachandran et al., 2010b). In addition, many of the EFTFs/RPC genes have been 
detected within Müller glia and their progenitor derivatives, including six3, pax6, rx1 (Rax) 
and vsx2 [see Figure 3a; (Bernardos et al., 2007; Lenkowski et al., 2013; Nagashima et al., 
2013; Qin et al., 2009; Raymond et al., 2006; Thummel et al., 2010)]. In the zebrafish retina, 
the transcription factor ascl1 is necessary for Müller glia transdifferentiation and retinal 
regeneration, and is upregulated within the Müller glia within six hours post-injury (Fausett 
and Goldman, 2006). More recently, it has been shown that ascl1a can directly drive the 
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pluripotency factor and RNA-binding protein lin-28, which further contributes to let7 
inhibition, a factor that has been shown to directly repress expression of regeneration-
associated genes, including ascl1a, lin-28, oct4, pax6b and c-myc (Nelson et al., 2012; 
Ramachandran et al., 2010a). Transcriptional repression also plays an important role in 
retinal regeneration; for example, the transcriptional repressor insm1 suppresses the Wnt 
antagonist dkk, resulting in the activation of the Wnt signalling pathway, which is required for 
progenitor proliferation (Ramachandran et al., 2012).    
 
Recently, EGF signalling has been shown to stimulate Müller glia de-differentiation via an 
epidermal growth factor receptor (EGFR)/MAPK-signalling pathway that impacts on 
regeneration-associated genes like asc1a, c-myc and pax6, resulting in the activation of both 
the Notch and Wnt signalling pathways. Furthermore, Wnt signalling has been shown to 
enhance the stimulation of Müller glia cells both with or without injury (Meyers et al., 2012; 
Ramachandran et al., 2011), and activation of Müller glia cells following injury leads to the 
upregulation of Notch signalling components, including deltaC, notch1 and notch3 (Raymond 
et al., 2006; Yurco and Cameron, 2005). Unlike mammals (see section 5.4.2.), Notch 
signalling in the zebrafish acts to suppress the formation of Müller glia-derived progenitors in 
the uninjured retina, whereas inhibition of this pathway leads to the expansion of the region 
of proliferating Müller glia cells (Wan et al., 2012).  
5.4.2. Müller Glia in Mammals 
 
In 2000, a seminal paper by Dyer and Cepko demonstrated that mammalian Müller glia 
could also be induced to proliferate in vivo in response to neurotoxic damage (Dyer and 
Cepko, 2000). Here, the authors showed that Müller glia down-regulate the tumour 
suppressor gene, p27Kip1, within the first 24 hours in response to ouabain and domoic acid-
induced injury. This and subsequent studies by Ooto et al. showed for the first time that the 
mammalian retina is capable of some degree of regeneration when exposed to appropriate 
stimuli (Ooto et al., 2004). Using the N-methyl-D-aspartate (NMDA) neurotoxicity model of 
retinal ganglion cell ablation, Ooto and colleagues showed that Müller glia cells re-enter the 
cell cycle 2 days post-injury in rat, similar to what has been previously reported in the chick 
and fish (Fischer and Reh, 2003; Raymond et al., 2006; Yurco and Cameron, 2005). 
Moreover, these newly generated cells upregulate the expression of the neural progenitor 
marker, Nestin, prior to expressing the mature retinal markers, protein kinase C (PKC) and 
neuron-speciﬁc enolase (NSE) as well as Rhodopsin and Recoverin, markers of early bipolar 
and photoreceptor cell differentiation, respectively (Ooto et al., 2004). Karl et al. (Karl et al., 
2008) found that Müller glia re-enter the cell cycle in response to NMDA retinal damage, and 
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upregulate Pax6, Notch and Dll1, similar to the responses reported in non-mammalian 
vertebrates, such as fish and chicks (Hayes et al., 2007; Kassen et al., 2007; Raymond et 
al., 2006; Yurco and Cameron, 2007). Finally, following MNU-induced photoreceptor 
degeneration, Müller glia cells initiated proliferation via a Cyclin D1 and Cyclin D3-dependent 
mechanism (Das et al., 2006a; Wan et al., 2007). A proportion of the resulting Müller glia-
derived cells went on to express the photopigment Rhodopsin as well as Synaptophysin, a 
presynaptic protein that labels only photoreceptor terminals, suggesting the potential for 
synapse formation (Wan et al., 2008). In each of these neurotoxic studies, Müller glial 
proliferation has been proposed to be a consequence of cell loss. Indeed, axotomy and laser 
injury models have similarly lead to re-entry into the cell cycle (Kohno et al., 2006; Panagis 
et al., 2005; Tackenberg et al., 2009; Xue et al., 2006). Interestingly, however, sub toxic 
injections of both glutamate and its analogue α-aminoadipate also result in augmented 
Müller glia proliferation and de-differentiation into neurons in vivo and in vitro (Takeda et al., 
2008).  
 
An increase in Nestin expression in Müller glia cells following injury is widely accepted as a 
marker of a move towards a state more similar to that of a neural progenitor. It is worth 
noting, however, that Xue et al., postulate that Nestin, an intermediate filament, may provide 
structural support to the degenerative retina and should not be taken purely as evidence of 
proliferation (Xue et al., 2006). Notably, the absence of a spontaneous injury-induced 
response from mammalian Müller glia cells implies that some mechanisms may be in place 
to limit proliferation of these cells in the adult mammalian retina. At least two, and probably 
many more, molecular mechanisms are employed within the adult retina to maintain Müller 
glia cells in a mitotically quiescent state. For instance, TGF-β2, which is produced by inner 
retinal neurons, activates the TGF-β receptors in Nestin-positive progenitor cells and 
GLAST-positive Müller glia cells, stimulating the expression of the cyclin dependent inhibitor, 
p27Kip1 (Close et al., 2005). Furthermore, the EGF receptor expression in Müller glia cells 
gradually declines as the retina matures, reducing their ability to respond to EGF and again 
inducing cytostasis. Interestingly, studies of light induced photoreceptor degeneration in 
albino rats have reported the upregulation of the EGF receptor in Müller glia cells, allowing 
for these cells to be driven into S-phase by intraocular EGF injections (Close et al., 2006).    
 
Supplementation with FGF2, EGF, activin-A, and insulin alone in the NMDA-injured eye fails 
to increase the proliferation of mammalian Müller glia cells further than that already activated 
by injury (Ooto et al., 2004). However, co-application of FGF2 and insulin to the neurotoxin-
injured (NDMA and KA) retina is able to augment the numbers of activated Müller cells in 
vivo (Das et al., 2006b). Karl et al. monitored the numbers of BrdU-positive cells within the 
 27 
course of a week post-injury and documented that an increase in BrdU-positive cells could 
be seen as early as 4h post-EGF supplementation, but that almost half were lost within 24h 
post-EGF addition. Nevertheless, a subset persisted and could be seen within the retina 30 
days post-injection (Karl et al., 2008). While it is not exactly clear why this decline occurs, it 
could represent the failure of the newly generated neurons to make stable synaptic 
connections, critical for their survival.    
 
Analyses of activated Müller glia cells following injury have demonstrated that these cells 
upregulate components of both the Wnt and Notch signalling pathways in response to retinal 
injury (Das et al., 2006a; Del Debbio et al., 2010; Liu et al., 2013). Exogenous application of 
Wnt2a, along with NMDA, is sufficient to induce a three-fold increase in the number of injury-
induced stem cell-like Müller glia cells as compared to eyes injected with neurotoxins alone, 
whereas application of the Wnt pathway antagonist, Fzd-CZD leads to a two-fold decrease in 
this cell population. DAPT, a Notch pathway inhibitor, has a similar effect. Of note, 
application of both the Wnt and Notch antagonists results in a lower injury-induced stem cell-
like Müller glia cell population compared to controls, and levels of CyclinA and CyclinD1 
transcripts are also decreased following Wnt and Notch attenuation. Together, these results 
indicate that the proliferation levels observed after Müller glia activation are likely due to the 
activation of the Wnt and Notch cascade (Das et al., 2006a). Finally, Shh has also been 
shown to regulate Müller glia proliferation following retinal injury. Intraocular injections of Shh 
following MNU-induced retinal damage results in an increase in BrdU-positive cells. 
Conversely, when injected with the Shh inhibitor, cyclopamine, proliferation is decreased in 
these retinas, in comparison to controls, suggesting that Shh signalling is activated 
endogenously following retinal injury (Wan et al., 2007), similar to the Wnt and Notch 
pathways.     
 
These findings demonstrate that the induction of known developmental signalling pathways 
after injury can stimulate the regeneration of Müller glia cells following retinal injury, beyond 
the response to injury alone. In addition to stimulating proliferation, these developmental 
pathways can also influence the cell fate adopted by these newly generated cells. For 
example, while supplementation of RA did not induce any changes in the numbers or 
location of BrdU-positive cells within the NDMA-injured rat retina, the authors reported a 
specific increase in the proportion of BrdU-positive/PKC-positive cells within the central 
retina, with no other changes to the differentiation of other retinal neuronal cell types (Ooto 
et al., 2004). This might indicate that supplementation with RA predominantly promotes a 
bipolar cell fate. However, subsequent work by Karl and colleagues using a reporter mouse 
line that expresses enhanced GFP under the metabotropic glutamate receptor 6 failed to 
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demonstrate an increase in bipolar cell number following RA stimulation (Karl et al., 2008). 
The use of the transgenic reporter line would be expected to be the more robust measure, 
compared to immunohistochemistry; however, the authors only administered a single 
injection of RA whereas Ooto et al. injected RA three times over the course of a week 
following NDMA damage. Such modifications in the protocols used may account for the 
differences in the results obtained. Interestingly, while Shh is normally secreted by ganglion 
cells and is known to directly control their genesis during embryonic retinal development, 
exogenous administration of Shh following retinal injury does not result in ganglion 
regeneration in vivo. Instead the Müller glia-derived progeny preferentially differentiate into 
rod-like cells, as indicated by an increase in Rhodopsin expression in the degenerative 
retinas following Shh treatment (Wan et al., 2007).  
 
Müller glial cells within the mammalian retina appear to at least attempt to generate cells, 
including photoreceptors following stimulation via growth factors and/or injury. However, 
additional studies are required to confirm whether differentiation is completed and whether or 
not these new cells are integrated into the existing circuitry. To date, only one study has 
aimed to address this. Using the S334ter rat model, which suffers retinal degeneration due 
to the premature termination of the Opsin mRNA translation, Del Debbio and colleagues 
demonstrated that following Müller glia activation in vivo induced by intravitreal injections of 
Wnt2b (wnt agonist) and Jag1 (Notch agonist) at P10 followed by Shh and DAPT (Notch 
antagonist) two days later, a rare subset of GS-positive/Opsin-positive (2.1%) cells can be 
detected within the ONL of the retina (Del Debbio et al., 2010). The same group have since 
reported that these cells are capable of driving the optokinetic head tracking response, 
where light perception is determined upon the head and neck movement in response to a 
visual stimulus. Although the number of new cells that expressed Opsin was small, the 
authors found a significant improvement in head tracking behaviour, close to wild type levels, 
17 days after Müller glia activation when compared with control untreated animals (Del 
Debbio et al., 2014).  
 
In addition to extrinsic signalling cues, intrinsic manipulations can also increase the potential 
of Müller glia-mediated regeneration. In both fish and chick, Ascl1a is required for retinal 
regeneration; in fish, ascl1a is upregulated within 6 hours of injury in the activated Müller glia 
cells, and is required for the increased proliferation and de-differentiation of these cells. 
While the mammalian homolog, Mash1 is not upregulated in the mammalian retina following 
injury (Karl et al., 2008), overexpression of Mash1 in dissociated mouse Müller glia cultures 
and retinal explants demonstrate that forced expression of this gene alone is sufficient to 
drive the upregulation of retinal progenitor markers, as well as down-regulating glial genes 
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through direct chromatin remodelling (Pollak et al., 2013). Following these induced changes, 
Müller glia cells are able to differentiate into a neuronal cell types as soon as six days post-
injury, as determined through their neuronal morphology and the upregulation of many 
retinal-specific markers, and furthermore, demonstrate signs of functionality in response to 
various neurotransmitter agonists, including NMDA and kainite (Pollak et al., 2013).  
 
While Ascl1 is sufficient to drive the expression of pan-neuronal and early retinal markers, 
the expression of photoreceptor genes, such as Rhodopsin and S-opsin is rare. In fact, the 
newly generated neuronal cells from the Ascl1-reprogrammed Müller glia primarily 
differentiate into bipolar cells (Pollak et al., 2013). Nevertheless, it may be possible to force 
expression of transcription factors of known importance during cell fate determination to 
manipulate the cell fate adopted by these Müller glia-derived cells. For instance, ectopic 
expression of Math3 and NeuroD with Pax6 is sufficient to promote an amacrine cell fate, 
whereas the combination of Crx and NeuroD allows for the generation of photoreceptor cell 
types (Ooto et al., 2004).   
 
Taken together, it seems likely that the Müller glia within the adult mammalian retina have 
the capability of proliferating and upregulating early neuronal markers in response to injury, 
similar to the cells contained with the CE. In contrast to the CE, these cells also demonstrate 
greater potential for differentiation into mature retinal neurons in vivo, as well as migrating 
within the neural retina to occupy the correct laminar region appropriate for the newly 
generated cell type. Given that Müller Glia are distributed throughout the lateral extent of the 
retina, these features offer the potential for widespread centre-periphery repopulation. 
However, despite the increase in proliferation exhibited by these cells following damage, the 
number of new cells generated appears to be relatively low. Ooto and colleagues suggest 
that reactivated Müller Glia are likely to only undergo a single division following injury before 
exiting the cell cycle (Ooto et al., 2004). It is not yet clear if it is possible to reactivate these 
cells in the face of sustained retinal degeneration, as occurs in disease, and if so, for how 
many divisions. Photoreceptor cells outnumber Müller glia cells in the mouse retina by a ratio 
of approximately 30:1 (Carter-Dawson and LaVail, 1979a). Thus, for transdifferentiation to 
be effective, every Müller glia cell would be required to undergo multiple rounds of division in 
order to adequately replenish the lost photoreceptors cells, while maintaining sufficient 
numbers of Müller glia cells to support the newly formed photoreceptors, as they do in the 
normal, uncompromised retina. These remain significant challenges that must be addressed. 
Nonetheless, the mammalian retina appears to harbour a latent regenerative potential that 
many hope might be sufficiently exploited in a therapeutic context to restore vision. 
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5.5. Summary of Endogenous Repair Mechanisms in Vertebrates 
 
In summary, while regeneration and repair is mediated by a variety of ocular cell sources 
within the lower vertebrate retina, widespread reactivation of these evolutionarily restricted 
mechanisms in mammals appears more limited. It is possible to induce a number of 
otherwise quiescent cell types to re-enter the cell cycle, at least as far as S-phase. However, 
our ability to guide these cells to generate differentiated cell types in numbers sufficient to 
mediate repair is, currently, poor. Probably the most encouraging, to date, is the potential for 
Müller glial cell reactivation. This cell type routinely generates new photoreceptors following 
injury and degeneration in the lower vertebrate retina and recent reports have indicated that 
it can be stimulated to produce differentiated neuronal cell types, albeit only low numbers of 
photoreceptors, thus far, in the mammalian retina. Moreover, it is arguably better placed 
anatomically to enable a widespread repopulation of the neural retina compared to those cell 
types located in peripheral ocular structures.  
6. Photoreceptor Transplantation  
 
We have made significant progress in defining the mechanisms that modulate endogenous 
retinal repair. However, we have yet to reach a state where these may be reactivated in the 
diseased mammalian retina to a level sufficient to restore visual function. For this reason, 
many have investigated an alternative, that of replacing the dead cells with new 
photoreceptors from exogenous sources (Figure 4). The transplanted cells would be 
expected to function in the same way as endogenous photoreceptors and, since they would 
connect into the existing circuitry, normal retinal processing would be maintained. It is 
increasingly clear that there are changes within the remaining retinal circuitry that may 
influence this processing [reviewed in (Jones et al., 2003; Jones and Marc, 2005; Vugler, 
2010)], but nonetheless, the extensive evidence from gene therapy (Bainbridge et al., 2008; 
Maguire et al., 2008) and the use of retinal implant devices (Caspi et al., 2009; Humayun et 
al., 2009) demonstrates that it is possible to restore visual function in the degenerating 
retina. This premise has led to significant interest in the potential for photoreceptor 
replacement.  
 
6.1. Defining the Appropriate Donor Cell 
Photoreceptor replacement has largely fallen into one of two strategies; replacement via the 
transplantation of a whole sheet of retina, often from neonatal sources, or by the 
transplantation of dissociated cell suspensions. A discussion of the former is outside the 
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scope of the current review but can be found in comprehensive reviews by Seiler and 
Aramant (2012), and Ghosh and Ehinger (2000) (Ghosh and Ehinger, 2000; Seiler and 
Aramant, 2012). Regarding cell suspension transplants, transplanted cells must migrate from 
the site of transplantation into the recipient retina, differentiate into photoreceptors and form 
new synaptic connections to inner retinal neurons. In our own studies, we have described 
this process as a cell becoming ‘integrated’ within the recipient retina, while defining the 
surgical process of delivering the donor cells into the eye as ‘transplantation’. Although many 
studies have routinely used the term integration following transplantation of stem cell-derived 
retinal cell types, a proper analysis of the “integrated” cell morphology is important. On this 
basis, we have described photoreceptors as integrated when they (1) show appropriate 
location in the ONL, (2) one of the inner or outer processes are visible, as well as (3) inner or 
outer segments and/or (4) synaptic bouton-like structures with the host INL (MacLaren et al., 
2006; Pearson et al., 2012) (Figure 4d).  
 
A major challenge has been to identify a donor cell source capable of completing this 
process of integration. The brain and the retina are both derived from a common source, the 
neuroectoderm. Given that immature neurons and progenitor cells are intrinsically capable of 
migrating and differentiating during development, numerous early studies into photoreceptor 
transplantation examined the potential of brain-derived neural stem/progenitor cells 
transplanted to the neural retina (Klassen et al., 2007; Mellough et al., 2007; Sakaguchi et 
al., 2004). Variously, cells have been introduced into the subretinal space (Figure 4c) and 
the intravitreal cavity. The subretinal space has the advantage of being immediately adjacent 
to the ONL, where the photoreceptors reside, while the intravitreal cavity is less invasive, 
being readily accessible via normal surgical procedures. While transplanted neural 
stem/progenitor cells can migrate into the adult retina, the migration is not restricted to the 
photoreceptor layer (Sakaguchi et al., 2005; Young et al., 2000). Moreover, these non-retinal 
sources of donor cells frequently fail to differentiate into mature retinal phenotypes as 
assessed by immunohistochemistry (Young et al., 2000). More recent studies using tissue-
restricted reporter genes have further confirmed that cells derived from such sources that 
are incorporated into the recipient retina fail to exhibit intrinsic features of mature retinal 
neurons (Sam et al., 2006). 
 
Many groups have subsequently examined the potential of donor cells isolated from 
embryonic retinas, which have the intrinsic potential to differentiate into retinal neurons. 
Different groups have tried transplanting these cells following different in vitro expansion and 
differentiation protocols prior to transplantation; depending upon the culture conditions used, 
the cells survive and differentiate into glial cells (Yang et al., 2002) and/or cells expressing 
 32 
retinal-specific markers, including some specific for photoreceptors (Qiu et al., 2005), 
following transplantation. However, they typically fail to correctly integrate into the neural 
retina, remaining instead at the site of transplantation. Greater success has been achieved 
when transplanting immature retinal cells into immature recipients, suggesting that the 
maturation state of the recipient may play a role in determining transplantation outcome: 
Murine RPCs transplanted into the eyes of neonatal Brazilian Opossums, which provide a 
foetal-like environment, survived and differentiated in vivo, although integrated cells were not 
found within the ONL, where photoreceptors normally reside (Sakaguchi et al., 2004). Since 
the same donor cells failed to migrate into the retina of more mature recipients, it was 
suggested that the age of the host tissue had a key role in determining the fate of 
transplanted progenitor cells and their ability to subsequently integrate into the circuitry of a 
non-autologous retina (Sakaguchi et al., 2003; Sakaguchi et al., 2004; Van Hoffelen et al., 
2003). 
 
Poor migration and integration of cells into the host retina could arise from either the intrinsic 
properties of the transplanted donor cells, from host retinal barriers, or more likely, a 
combination of both. By using postnatal donor cells from a transgenic mouse ubiquitously 
expressing GFP and taking these cells from the peak of rod photoreceptor genesis and 
transplanting them into recipients of exactly the same developmental stage, we found that 
the transplanted cells migrated into the ONL (and no other layer) of the recipient retina and 
matured into morphologically normal photoreceptors [Figure 4; (MacLaren et al., 2006)]. 
Moreover, in contrast to progenitor cells (Sakaguchi et al., 2003; Sakaguchi et al., 2004), 
these same cells could also integrate with similar efficiency into the non-neurogenic, adult 
retinal environment [(MacLaren et al., 2006), see also (Bartsch et al., 2008) and (Kwan et al., 
1999)]. This indicated that transplantation success depended upon the developmental stage 
of the donor cell, rather than that of the recipient. The reports by both MacLaren, Pearson et 
al. and Bartsch et al. demonstrated a strong dependence on the age of the donor cell at the 
time of transplantation, with efficiency being best when donor cells were taken from around 
P4, compared to earlier or later developmental stages. The rod-specific transcription factor 
Nrl is first expressed shortly after terminal mitosis [see section 4.2.1.; (Akimoto et al., 2006)]. 
By using the Nrl.GFP transgenic mouse line, in which GFP expression in the retina is 
restricted to post-mitotic rod photoreceptors, we were able to demonstrate that effective 
transplantation is only achieved using post-mitotic photoreceptor precursor cells, cells that 
are specified to differentiate into rod photoreceptors, rather than progenitor cells or 
photoreceptors at other stages of development (Lakowski et al., 2010; MacLaren et al., 
2006; Pearson et al., 2012). Although we found adult photoreceptor cells to be very poor 
donors, a report by Reh and colleagues indicates that fully mature photoreceptors can also 
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integrate within the wild type retina, but exhibited poorer survival (Gust and Reh, 2011). We 
have since found that it is indeed possible for mature photoreceptors to integrate, but that 
they do so with markedly lower efficiency, even when accounting for reduced viability 
(Gonzalez-Cordero et al., 2013; Pearson et al., 2012). Taken together, photoreceptor 
transplantation is possible, even into the mature recipient retina, but optimal transplantation 
is achieved when the donor cells are at the correct stage in development at the time of 
transplantation (Bartsch et al., 2008; MacLaren et al., 2006) (summarised in Table 1). 
 
The ability to replace cone photoreceptors is of significant importance for clinical application. 
Cone transplantation has, however, proved challenging. We previously reported that it is 
possible to transplant small numbers of cones using a Crx.GFP reporter line to isolate 
photoreceptor precursors at different stages of development (Lakowski et al., 2010). Again, 
these cells were post-mitotic and their developmental stage influenced the efficiency of cone 
transplantation, with mature cones integrating very poorly (Barber, Pearson, unpublished 
data). In each of these studies, the numbers of integrated cones was very low. In a recent 
study, Ader and colleagues used rods that had been genetically engineered to remove Nrl, 
turning them into cells with cone-like properties (Mears et al., 2001a). Following 
transplantation, these cells integrated with moderate efficiency and expressed cone markers, 
despite frequently adopting a more rod-like morphology (Santos-Ferreira et al., 2014).   
 
Cell-cell fusion is a physiological mechanism that controls a number of developmental 
processes. In transplantation paradigms, it has also been shown to explain formation of 
stable heterokaryons and synkaryons following the transplantation of hematopoietic stem 
cells (Terada et al., 2002; Weimann et al., 2003; Ying et al., 2002). Indeed, a recent study in 
the retina showed that transplanted hematopoietic stem cells can fuse with retinal neurons in 
the damaged retina and re-programme them to a more immature state (Sanges et al., 2013). 
Fusion has been considered unlikely to occur in the retina following photoreceptor 
transplantation since the donor cells used in the majority of the reported studies are post-
mitotic, and, to the authors’ knowledge, there have been no reports of fusion between two 
post-mitotic neurons. Nonetheless, the issue of cell fusion following photoreceptor 
transplantation has been addressed in a number of studies. Donor cells transplanted into 
knockout models of inherited blindness express the protein missing in the recipient 
endogenous photoreceptors (e.g. Rod -transducin in the Gnat1-/- knockout, Rhodopsin in 
the Rho-/-). In MacLaren et al., the authors used a permanent nuclear marker used to label 
only the donor cells, which demonstrated the presence of GFP-positive cells within the 
recipient retina that contained a single nucleus bearing the nuclear label. They also 
transplanted GFP donor cells into recipients ubiquitously expressing cyan fluorescent protein 
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(CFP) and found integrated GFP-positive cells with no co-localisation of the CFP fluorescent 
signal (MacLaren et al., 2006). In an independent study, Bartsch et al. reported the same 
finding following the transplantation of donor cells electroporated with tdTomato into 
recipients that ubiquitously expressed eGFP (Bartsch et al., 2008). In a more recent study, 
Eberle et al., (2011) used donor cells derived from a double-crossed transgenic line in which 
eGFP is fused to human Rhodopsin protein and DsRed is expressed under the control of the 
-actin promoter. Here, integrated cells expressed both DsRed (cell body) and GFP 
(localised only to the outer segment) in the correct anatomical locations (Eberle et al., 2011). 
Note that in the studies described, the recipient retinae are not degenerating; however, a 
recent report by MacLaren and colleagues has also demonstrated the absence of fusion 
following transplantation into the degenerating retina (Singh et al., 2013a).  
 
6.2. Function 
Collectively, there is significant evidence showing that transplanted rod-precursor cells 
derived from the developing retina are able to migrate into the adult retina and differentiate 
over a period of several weeks to acquire the specialized morphological features of mature 
photoreceptor cells (Bartsch et al., 2008; Eberle et al., 2011; Eberle et al., 2012; Kwan et al., 
1999; MacLaren et al., 2006; Pearson et al., 2012; Warre-Cornish et al., 2014). However, the 
fundamental question remained as to whether these transplanted photoreceptor cells could 
actually improve function. A major challenge for the cell suspension approach was, and 
indeed still is, to generate sufficient numbers of transplantable cells and in parallel to achieve 
high and consistent levels of integration. By optimizing the transplantation protocols 
sufficiently to increase integration ~ 20-30 fold, we were able to demonstrate rod-mediated 
vision after photoreceptor transplantation in a mouse model of congenital stationary night 
blindness, the Gnat1-/- mouse (Pearson et al., 2012). A time-course study of the period 
immediately after transplantation revealed that by 6 weeks post-transplantation ~95% of 
GFP+ve -transducin, the protein 
missing in the endogenous photoreceptors of the recipient, in their outer segments (Warre-
Cornish et al., 2014). Suction electrode recordings revealed that the newly integrated donor 
rod cells are light sensitive and display dim-flash kinetics very similar to wild type rods. 
Moreover, the dim light-evoked signals generated by transplanted rods are projected to 
higher visual areas, including V1 of the visual cortex, and are capable of driving at least 
some forms of visually-guided behaviour (Pearson et al., 2012). These findings support 
previous studies of single measures of function, including simple light-dark preference and 
wheel running tests following the transplantation of retinal cell suspensions derived from 
early postnatal retinae (Klassen et al., 2004; Kwan et al., 1999). Takahashi and colleagues 
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recently reported a physiological characterisation of Nrl.GFP donor cells transplanted into 
the Crx-/- recipient, which lacks outer segments and is non-functional, and similarly reported 
that integrated donor cells formed new outer segments and presented Ca2+ responses and 
rectifier outward currents similar to wild type photoreceptors (Homma et al., 2013). The 
electroretinogram (ERG) is recorded at the corneal surface and is an average of the 
electrical responses of all the cells in the retina in response to a light stimulus. It is one of the 
most commonly used assessments of visual function. Despite robust integration of 
transplanted photoreceptors, however, the levels achieved thus far still appear insufficient to 
drive a robust ERG response in the recipient retinae (Pearson et al., 2012). By using gene 
replacement in the same model, we found that approximately 120,000 functioning rod 
photoreceptors were required to generate a reproducible scotopic ERG response (Pearson 
et al., 2012). Taken together, there is an increasing body of evidence demonstrating the 
ability to restore visual function in the diseased retina following the transplantation of 
immature photoreceptors (see also, section 8.2.). 
6.3. Challenges Facing Transplantation  
 
The work of the last decade or so has demonstrated that photoreceptor transplantation is 
possible and that the new cells are capable of driving visual function. However, a number of 
major challenges must be addressed before this strategy can be applied clinically. These 
include, amongst others, the achievement of high levels of integration and long-term survival 
of donor cells within the severely degenerate retina and the establishment of protocols for 
the robust generation of transplantable populations of donor cells from a renewable source.    
The most successful transplants have, thus far, been achieved either in wild type animals or 
in models with only slow to moderate degeneration. Donor cells transplanted into the 
subretinal space must migrate out from the cell mass, through the recipient 
interphotoreceptor matrix (IPM). They must then cross the outer limiting membrane (OLM), a 
series of adherens junctions formed between photoreceptors and Müller glia, before 
migrating through the ONL to an appropriate position (Warre-Cornish et al., 2014). Thus, in 
addition to the donor cell being at the correct stage in development, their interactions with 
the recipient retinal environment are also likely to be key in determining transplantation 
outcome. Accordingly, the diseased retina presents a new set of challenges. A 
comprehensive review of the challenges presented by the disease retina to photoreceptor 
transplantation is beyond the scope of this review, but is considered in depth elsewhere 
(Pearson, 2014).  
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Briefly, the cytoarchitecture of the recipient ONL becomes disrupted and the OLM can in 
some, but not all, cases become compromised (RAP, unpublished data). The latter may be 
beneficial to transplantation since the OLM may represent a physical barrier to the migration 
of donor cells into the ONL (Pearson et al., 2010; West et al., 2008). However, another major 
feature of retinal degeneration is Müller glial cell reactive gliosis; the resulting glial scar can 
envelop the entire retina at late stages of degeneration (Jones et al., 2003). Not only does 
this scar form a physical barrier between injured and healthy tissue, it can also act as a 
reservoir for the accumulation of inhibitory ECM proteins, including chondroitin sulphate 
proteoglycans (CSPGs), which are known to be inhibitory to axonal regeneration 
(Theocharis et al., 2010). 
 
We recently reported the first comprehensive study comparing rod transplantation into 6 
different models of inherited degeneration (Barber et al., 2013). Importantly, the severity of 
degeneration was not a determining factor in transplantation outcome and robust donor cell 
integration was observed, even at late stages of degeneration in some (Barber et al., 2013), 
as also reported by others (Kwan et al., 1999; Singh et al., 2013b). This is important since, at 
least initially, such novel therapies would likely be applied to only very advanced cases. 
However, the aetiology associated with a given disease type was shown to impact 
significantly on both the number and the morphology of integrated rods.  
 
In particular, we noted an inverse correlation between the extent of gliosis in the recipient 
retina and the number of integrated cells (Barber et al., 2013). Glial scarring has been 
proposed to explain the lack of integration of retinal sheets with the host retina, as neurite 
extension does not occur in regions of reactive gliosis (Zhang et al., 2003). Similarly, 
dissociated hippocampus-derived neuronal progenitors integrated poorly in the adult retina 
of dystrophic rats compared with non-dystrophic animals (Young et al., 2000). Confusingly, 
gliosis has been reported to have beneficial, as well as negative, effects on transplantation 
strategies; Nishida et al. reported that the upregulation of intermediate filament proteins 
following retinal damage may actually promote the survival of transplanted neuronal stem 
cells (Nishida et al., 2000). Gliosis is complex process, however, and assessments made on 
the basis of intermediate filament protein expression alone may be misleading. CSPGs are 
upregulated in response to injury and disease throughout the CNS (Fawcett, 2009; Gumy et 
al., 2010; Inatani et al., 2000) and participate in the inhibition of axon regeneration (Crespo 
et al., 2007; Friedlander et al., 1994; Gilbert et al., 2005). With respect to transplantation, 
they are likely to present a repulsive barrier to transplanted donor cells. We have found very 
different patterns of CSPG expression in different models of degeneration, as assessed with 
the broad-spectrum CSPG antibody CS-56 (Barber et al., 2013) (Hippert, Graca et al., in 
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press). Moreover, levels of CSPGs in the recipient IPM are inversely correlated with the 
number of integrated donor cells post-transplantation (Barber et al., 2013). Strategies that 
prevent the formation of inhibitory CSPGs, or break them down, are of significant interest for 
improving the outcome of cell regeneration and replacement strategies. The bacterial 
enzyme chondroitinase ABC (ChABC) degrades CSPG side chains and has been reported 
to promote functional recovery (Bradbury et al., 2007; Crespo et al., 2007) and structural 
plasticity (Fawcett, 2009) after spinal cord damage. These principles have been applied in 
the retina with encouraging results with several studies demonstrating that co-treatment with 
ChABC at the time of transplantation leads to significant increases in the number of 
integrated cells (Barber et al., 2013; Ma et al., 2011; Suzuki et al., 2007).  
 
Another major consideration for cell replacement is the long-term survival of the integrated 
cells in a foreign environment. The eye is frequently described as being immune-privileged. 
However, photoreceptor cell death is associated with activation of the resident macrophage 
population, called microglia. The presence of increased numbers of macrophages shortly 
after cell transplantation is associated with significantly fewer integrated photoreceptors in 
wild type mice (Warre-Cornish et al., 2014; West et al., 2010). Immune privilege is further 
compromised if RPE cells die or the outer blood-retinal barrier is disrupted (Wenkel and 
Streilein, 1998), as often occurs in degenerating or injured retinae. The transplantation 
procedure itself introduces further, albeit localised, trauma. Together, these have significant 
implications for photoreceptor transplantation. A number of tissue sources are under 
consideration for photoreceptor replacement therapy, including ESCs, induced Pluripotent 
Stem Cells (iPSCs), and dissociated cells either from acute tissue isolation or from cultured 
populations (see below), as well as the transplantation of whole retinal sheets (Seiler and 
Aramant, 2012). Many of these will have an immune profile different to the cells of the 
recipient retina.  
 
Few studies have examined the survival of retinal cells transplanted to the subretinal space, 
although a number of studies have examined the long-term survival of neural 
stem/progenitor cells. Interestingly, cultured neural progenitors appear to be less 
immunogeneic, compared with freshly dissociated neural progenitors, even following xeno-
transplantation (Hori et al., 2003; Ma and Streilein, 1998). Similarly, others have 
demonstrated good survival of cultured retinal allografts in pigs at 10 weeks post-
transplantation (Warfvinge et al., 2006). The survival of the transplanted cells in these 
studies was evaluated by examining the mass of cells present in the subretinal space 
(Warfvinge et al., 2006; Wojciechowski et al., 2002). By transplanting post-mitotic 
photoreceptor precursor cells, we further sought to assess the ability of integrated donor 
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photoreceptors to survive within recipient retinas with partially mismatched haplotypes. We 
found that transplanted photoreceptor cells integrated within the adult mouse retina are 
subject to a delayed host immune response from around four months post-transplantation. 
However, they can survive for extended periods of time, up to a year, provided these 
immune responses are modulated (West et al., 2010). These are promising results but do 
demonstrate that the host immune system must be added to the factors to consider when 
assessing the relative merits of the different donor cell types. 
 
Another major challenge, and the one that is discussed in detail in sections 7 & 8 (also 
summarised in Table 1), is the scalable generation of donor cells suitable for transplantation. 
The studies outlined in section 6.1 indicate that donor cells need to be at an appropriate 
developmental stage, post-mitotic precursors, at the time of transplantation for optimal 
integration. However, photoreceptor genesis in humans occurs between weeks 11 and 16 
(O'Brien et al., 2003). This presents not only an ethical but also a practical problem; it is not 
possible to acquire sufficient donor cell material from developing embryos and we thus 
require an alternative donor cell source. Stem cells themselves appear to have limited 
potential to generate new photoreceptors when directly transplanted. However, if they can 
be directed towards the photoreceptor precursor stage in vitro, they should, in theory, have 
the potential for effective transplantation when placed in vivo. This is a formidable challenge, 
but by using the wealth of knowledge surrounding the intrinsic and extrinsic factors required 
for proper retinal development and regeneration, researchers are now taking major steps 
towards achieving it.  
 
7. Directed Differentiation of Ocular Stem/Progenitor Cells to Generate 
Transplantation-Competent Donor Cells 
 
Given the at least partial regenerative capacity of the eye itself, there has been considerable 
interest in the use of ocular stem cell populations as a source for the targeted generation of 
donor photoreceptors for transplantation. Below we consider the progress made and our 
current understanding of the potential of the different ocular structures as a source of donor 
photoreceptors for transplantation (Figure 1b and summarised in Table 1).  
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7.1. De-Differentiation of Pigmented Epithelial Cells 
 
Pigmented epithelial cells of the mammalian CE, RPE and iris have generated much interest 
in the field retinal stem cell biology and cell transplantation therapies for retinal degenerative 
diseases as a potential source of donor cells. They are embryonically related to the neural 
retina and can be obtained relatively easily through surgery, meaning that they could be 
obtained from the patient (i.e. they are autologous). While only limited regeneration potential 
has been documented in vivo (section 5), in vitro studies have demonstrated that these cells 
can be expanded in culture. 
 
7.1.1. Ciliary Epithelium-Derived Stem Cells 
 
Although the mammalian adult retina appears to have restricted regenerative capabilities 
(section 5.1.2), Van der Kooy and Ahmad independently reported that the mammalian CE 
contains a population of retinal stem cells (Ahmad et al., 2000; Tropepe et al., 2000). 
Dispersed throughout the pigmented epithelium, these proposed retinal stem cells represent 
a very rare population (approximately 0.2% of CE pigmented cells), and under normal 
conditions remain quiescent during adult life. However, when isolated from the eye and 
cultured in vitro, these cells demonstrate characteristics typical of neural stem cells, 
including self-renewal and multipotency. With or without exogenous growth factor stimulation 
(typically FGF2 and/or EGF), these single pigmented cells clonally proliferate to form sphere 
colonies containing similar proportions of pigmented and non-pigmented cells. Despite their 
heavy pigmentation, non-pigmented colony-forming stem cells can be derived from albino 
animals, suggesting that the biochemical properties of pigment formation are not required for 
stem cell function (Ahmad et al., 2000; Tropepe et al., 2000). While initially identified in 
rodents, these cells have subsequently been isolated from rabbit (Inoue et al., 2005), pig (Gu 
et al., 2007; Macneil et al., 2007), monkey (Martinez-Navarrete et al., 2008) and human 
(Bhatia et al., 2009; Coles et al., 2004; Jasty et al., 2012; Martinez-Navarrete et al., 2008; 
Mayer et al., 2005; Moe et al., 2009; Xu et al., 2007a) eyes, suggesting an evolutionary 
conservation of this population in the adult vertebrate eye.  
 
Demonstrating a cardinal feature of stem cells, the resulting neurospheres can be 
dissociated and grown after several passages, though many reports have suggested that the 
growth of these cells as free-forming spheres become less vigorous after multiple passages, 
especially when compared to brain-derived neural stem cells (Moe et al., 2009; Xu et al., 
2007a; Yanagi et al., 2006). However, these cells have a broader expansion potential when 
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cultured as monolayers, maintaining a progenitor phenotype (Coles et al., 2004; Gualdoni et 
al., 2010; Macneil et al., 2007; Xu et al., 2007a). Comparing mouse, rat and human derived 
CB retinal stem/progenitor cells, human-derived CB cells formed similar numbers of 
neurospheres colonies after one week in culture; however the average numbers of cells 
within each sphere was substantially less than in rodents. This could reflect the differences 
in development between the species, or could represent a more limited and restricted stem 
cell potential through the course of evolution (Xu et al., 2007a).  
 
These cells are also capable of responding to a number of exogenous signalling molecules 
in vitro; increased proliferation of these cells has been documented following 
supplementation with (i) SCF (stem cell factor), which is believed to act via the c-Kit receptor 
(Das et al., 2004), (ii) Notch signalling as observed through the upregulation of the Notch1 
receptor (Das et al., 2004), as well as (iii) the canonical Wnt pathway mediated through 
Wnt3a (Das et al., 2006b). More recently, Balenci and colleagues demonstrated that the 
proliferative behaviour of these adult retinal stem/progenitor cells in vitro reduces when 
exposed to members of the BMPs, specifically BMP2 and BMP4 (Balenci et al., 2013). In 
this screening, secreted Frizzled-related protein 2 (sFRP2) also reduced the numbers of 
adult retinal stem cell primary spheres. Interestingly, the authors noted that these factors are 
secreted by the adult mouse cornea and lens, implying that the continued quiescence of 
these cells in vivo in the face of damage or retinal degeneration (see section 5.1.2) may be 
due, at least in part, to their inhibition by the secretion of a combination of factors by 
surrounding tissues (Balenci et al., 2013).  
 
Several teams have tried to expand and subsequently differentiate CE-derived progenitor 
cells (Ahmad et al., 2000; Coles et al., 2004; Das et al., 2005; Tropepe et al., 2000; Xu et al., 
2007a). After several days in culture, these cells express early neuronal markers, such as 
Nestin and Vsx2, indicative of differentiation into a neural cell lineage. Transcriptome 
profiling of CE-derived stem/progenitor cells demonstrates that they share 80% of genes 
with early retinal progenitor cells, but considerably fewer with late retinal progenitors (Das et 
al., 2005). Similarly, these cells express the FGF receptor, FGFR1, when cultured without 
the presence of exogenous GF stimulation, as do early progenitors in vivo (Giordano et al., 
2007). Das et al. reported that these CE-derived cells preferentially produce earlier born 
retinal cells in vitro (Das et al., 2005), although others have reported their differentiation into 
later born cell types, including rods and bipolar cells. There remains some uncertainty in the 
field as to whether or not CE-derived progenitor cells are truly multipotent and thus fulfil an 
important criterion of true stem cells (Cicero et al., 2009; Gualdoni et al., 2010; Moe et al., 
2009; Yanagi et al., 2006). A number of reports found expression of the rod photoreceptor 
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marker, Rhodopsin, following differentiation (Asami et al., 2007; Coles et al., 2004; Tropepe 
et al., 2000), although other studies have failed to convincingly detect this marker by 
immunohistochemistry (Cicero et al., 2009; Gualdoni et al., 2010; Macneil et al., 2007). 
Using the Nrl.GFP transgenic reporter line that expresses GFP in the developing and mature 
rod photoreceptors, Gualdoni et al. found that the rod differentiation cascade was not 
initiated in the CE-derived retinal stem/progenitor cells in vitro when using a number of 
standard differentiation conditions previously reported to generate rod photoreceptors. They 
demonstrated that these CE cells do possess the ability to proliferate in culture, 
concomitantly losing their pigmentation over time and expressing a subset of eye field and 
retinal progenitor markers. However, they also maintained expression of some markers of 
differentiated CE and typically lacked a neural morphology (Gualdoni et al., 2010).   
 
This study supports previous work in which Cicero and colleagues proposed that both 
murine and human CE-derived neurospheres consisted of proliferating pigmented epithelial 
cells rather than true retinal stem cells or progenitors. Dyer, Cicero and colleagues used 
gene expression studies to show that these cells express markers of the mature CE, rather 
than genes normally expressed in retinal progenitor cells or stem cells. Lastly, the authors 
showed that a subset of these cells, approximately 17%, became Nestin-positive but that 
expression was not sustained, and the cells failed to adopt a mature retinal phenotype. 
Collectively, these results challenge the idea of a true retinal stem cell population within the 
mammalian CB, instead supporting the notion of partial CE transdifferentiation. However, 
they do not rule out the existence of a rare dormant stem cell. The fact that only a very small 
proportion of CE cells are capable of giving rise to retinal neurospheres in vitro argues 
against CE transdifferentiation. More recent studies have demonstrated that these sphere-
initiating cells can be prospectively enriched based upon size, pigmentation density and the 
low expression of P-cadherin as well as high Pax6 expression (Ballios et al., 2012; Demontis 
et al., 2012; Inoue et al., 2010; Xu et al., 2007b). When sorted on the basis of size and 
pigmentation criteria, Ballios et al. reported that this population is more efficient at generating 
spheres than other cells within the CE (Ballios et al., 2012). Moreover, when cultured in the 
presence of factors required for rod photoreceptor maturation, including taurine, RA, Shh 
and FGF2 (see section 4.2.1; Figure 2b), Rhodopsin expression was increased, and when 
cultured for extended periods of time (up to 44 days), these cells lost their pigmentation and 
ciliation, and adopted a retinal morphology, indistinguishable from cultured primary 
photoreceptor precursors (Ballios et al., 2012; Demontis et al., 2012).  
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It may be premature to reach a final conclusion on this topic based purely upon sequential 
marker expression and in vitro morphological analyses alone. Like many protocols to 
differentiate other pluripotent stem cell types (see section 8.1), these cells do not form outer 
segments in vitro (Ballios et al., 2012). Whether they can be induced to do so using the 
newly described 3D culture techniques (see section 8.1) remains to be seen and a full 
characterisation, including functional studies, of the progeny of these CE-derived cells is still 
required. Nonetheless, three independent studies, on both mouse and human CE-derived 
cells, have shown these newly differentiated cells are functionally responsive, as 
demonstrated through the acquisition of electrophysiological characteristics (Del Debbio et 
al., 2013; Demontis et al., 2012; Jasty et al., 2012). In one instance, using the AAV2/8-p-
Rho-eGFP construct, Demontis et al. demonstrated that single eGFP-positive cells 
expressed cGMP channels gated by endogenous cGMP, as well as voltage-gated channels, 
typical of rod maturation. Furthermore, they showed that these cells displayed rudimentary 
responses to light reminiscent of P10 rats and developing rods in Xenopus tadpoles, whose 
light responses are of smaller amplitude and lower sensitivity than those of their adult 
counterparts (Demontis et al., 2012).      
 
The debate over the identity and multipotency of CE cells highlights an important issue with 
many studies attempting to characterise multipotency, particularly the heavy dependency on 
the expression of single markers, such as Rhodopsin, for the assessment of retinal neuronal 
potential. Moreover, many studies assess the expression any given marker by just one 
technique, typically immunohistochemistry. These may lead to erroneous conclusions both 
about the potential of these cells, and the culture conditions that generate them. Such 
problems stand to be addressed by the increasingly elegant studies that use transgenic and 
viral reporter lines. To summarise, it remains possible that CE-derived cells could be 
harnessed for clinical cell transplantation once a number of obstacles associated with 
lineage conversion and cell number expansion are overcome.  
7.1.2. RPE-Derived Stem Cells 
 
Initial studies monitoring the in vitro potential of RPE-derived cells reported that these cells 
lacked the ability to generate neurospheres in vitro from both mouse and human RPE 
tissues (Coles et al., 2004; Tropepe et al., 2000). However, following subsequent 
modifications designed to improve the clonal growth and expansion of adult neural stem 
cells in vitro (Wachs et al., 2003), Engelhardt and colleagues were able to demonstrate that 
rat RPE cells, when dissociated and cultured in vitro, express the neural progenitor markers, 
Nestin and Musashi1, while down-regulating RPE-specific markers, including RPE65 
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(Engelhardt et al., 2005). Similar to the CB, these cells are able to proliferate in vitro under 
both adherent and neurosphere conditions, although expansion was more limited. A low 
proportion of these cells were able to differentiate in vitro into neuronal cells, as determined 
through the expression of the neuronal marker β-III tubulin, and Doublecortin, a specific 
marker for neuronal precursors (Lee et al., 2003), and the adoption of a neuronal 
morphology. Despite this, further cultivation of these cells under these differentiating 
conditions (removal of growth factors and addition of 5% serum) failed to give rise to a more 
mature retinal phenotype, indicating that, at least under the culture conditions used within 
this study, RPE cells are capable of de-differentiating into a young neuronal phenotype, but 
lack the capacity of retinal maturation (Engelhardt et al., 2005). 
 
Promisingly, more recent work by Temple and colleagues has shown for the first time that 
RPE tissue derived from human adult donors can be successfully coaxed into a multipotent 
state (Salero et al., 2012). These cells are able to undergo several rounds of division 
(doubling approximately every two days) when cultured under adherent conditions, prior to 
differentiation into multiple lineages, including CNS and mesoderm-associated lineages. 
Under these conditions, proliferation was stimulated by serum alone, and the cells could be 
passaged at least six-eight times. Surprisingly, RPE cells harvested from 99-year-old donors 
were also shown to produce actively growing cultures, similar to the growth of RPE cells 
derived from younger donors, suggesting that donor age is not an impediment to expanding 
these cells in vitro. When grown under clonal, non-adherent conditions, these cells form 
neurospheres in the presence of knockout serum replacement media and FGF2. Primary 
neurospheres were visible after four days in vitro and could be passaged at least three 
times. While these dissociated RPE cells were able to form neurospheres in culture, it was 
noted that these cells grew more readily when plated under adherent conditions, most likely 
reflecting the importance of cell-cell interactions and cell adhesion for RPE growth.  
 
Of value for transplantation, RPE-derived progenitor cells are capable of fate change when 
grown in conditions to promote retinal differentiation, which included the addition of Fgf2, 
Fgf8, Shh and RA. Under these conditions, gene expression analyses demonstrated that 
these cells are able to upregulate the expression of Nestin by 1000-fold, and β-tubulin III by 
90-fold. Furthermore, these cells expressed markers consistent with the early forebrain/eye 
field lineage, including LHX2, OTX2, and RAX. However, the expression of more mature 
retinal markers, including RHODOPSIN and VSX2, did not increase, demonstrating a limited 
potential to differentiate towards mature retinal neuronal phenotypes under these 
differentiation conditions. Importantly, it should be noted that these cells were cultured for 
four weeks, a relatively short time in terms of human development. Those protocols reporting 
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a promising photoreceptor-like morphology from murine CE-derived cells were maintained 
for a culture period of 44 days (Ballios et al., 2012; Demontis et al., 2012; Salero et al., 
2012). Collectively, these findings yield hope for the use of RPE cells for autologous or 
allogenic replacement therapies and a thorough assessment of the differentiation potential of 
these cells with the use of more sophisticated methods (as outlined in section 8.1) will be 
important (Salero et al., 2012). 
7.1.3. Iris-Derived Stem Cells 
 
While reports of iris-derived transdifferentiation have not been documented in vivo, in vitro 
studies have indicated that a subset of these cells retain the potential to generate 
neurospheres when removed from their in vivo environment. Neurospheres from these cells 
can be derived from early postnatal through to adult stages in mouse, rat and human, 
although the number of neurospheres generated declines with age (Asami et al., 2007; Jasty 
et al., 2012). Application of exogenous growth factors (FGF2) demonstrates that while 
neurospheres can form without stimulation, the presence of growth factors results in a 3.5-
fold increase in neurospheres generation. Furthermore, enrichment of Nestin-positive cells 
via the use of a transgenic reporter line driving GFP expression from the Nestin promoter 
(Yamaguchi et al., 2000), results in a more pronounced capability of these cells to form 
neurospheres. Similarly, enrichment of neurospheres-initiating cells from the IPE is also 
achievable by Fluorescence-Activated Cell Sorting (FACS) for the cell surface marker 
CD133, a broad marker associated with both neural and haematopoietic stem cells. 
Following this selection criterion, a greater number of neurospheres are formed, in fact even 
greater than the Nestin-positive IPE subpopulation. Further analyses of CD133-positive and 
negative populations demonstrates that the CD133-positive fraction of cells yields spheres 
containing more proliferative cells, some of which express Nestin and Musashi1, whereas 
some of the CD133-negative cells are shown to acquire TuJ and/or Nestin expression, 
adopting more of a neuronal morphology. The CD133-positive population therefore appears 
to represent the proliferative population of cells, and as such, could be used for enrichment 
prior to differentiation in vitro (Asami et al., 2007). Whether CD133 represents a positive 
selector for stem like cells in other regions, like the CE, is not known. 
 
While capable of proliferating in vitro, IPE-derived cells also possess the ability of 
transdifferentiating into neuronal cell types, without proliferating. Following culture with 
FGF2, IPE-derived cells increase mRNA expression of pro-neural genes, including Nestin, 
Notch, Otx2 and Pax6, while concomitantly undergoing pigment elimination (Asami et al., 
2007). Furthermore, prolonged culture in the presence of fetal bovine serum (FBS) induces 
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the expression of Rhodopsin (photoreceptor cells), TuJ, Glutamine Synthetase (Müller glia 
cells) and HPCl/syntaxin (amacrine cells). Similar to these rodent studies, pigmented porcine 
iris cells have also been shown to proliferate, to form spheres, and to differentiate into 
neurons and glia, although retinal-specific markers were not expressed under the conditions 
used in this study (Macneil et al., 2007). More recently, human iris tissue acquired following 
iridectomies has been shown to be equally capable of proliferating and expressing neural 
progenitor markers, including Pax6, Sox2 and Nestin. Again, however, the IPE-derived cells 
show only partial neuronal differentiation, expressing -III-tubulin, Map-2 and Rhodopsin, 
whilst retaining their differentiated epithelial phenotype (Froen et al., 2011).  
 
While differentiation of IPE cells into photoreceptors is rare, it is possible to induce the 
expression of photoreceptor-specific markers by means of gene transfer (Akagi et al., 2004; 
Akagi et al., 2005; Haruta et al., 2001). For instance, mis-expression of Crx induces rat IPE 
cells to express several photoreceptor specific antigens, including Rhodopsin, Recoverin 
and Arrestin (Akagi et al., 2004; Akagi et al., 2005). Interestingly, in primates, forced 
expression of both NeuroD and Crx in combination is required to induce a photoreceptor-like 
phenotype, demonstrating that this approach, although slightly altered from that of rodents, 
is feasible in higher vertebrates.  
 
7.2. Müller Glia-Derived Stem Cells 
 
In keeping with the progenitor-like profile that Müller glia can adopt in lower vertebrates, 
Müller glia cells of the mature mammalian retina share significant transcriptome overlap with 
retinal progenitor cells (Blackshaw et al., 2004; Roesch et al., 2008). Given these properties, 
it has been postulated that these cells could provide a source of retinal neuronal cells within 
the adult mammalian retina. Confusingly, however, when using the neurosphere assay, 
Tropepe and colleagues reported no production of neurospheres from the adult central 
retina. This may mean that the central retina of mature mammals lacks the same self-
renewal properties demonstrated in lower vertebrates, and/or may not be able to respond to 
the neurosphere culture conditions. In line with the latter, Das et al., demonstrated that 
Müller glia cells obtained from adult rats can be cultured under proliferative conditions before 
being transferred to neurosphere-generating conditions. These conditions resulted in a small 
subset (0.18%) of retrospectively enriched Müller glia cells that can generate clonal 
neurospheres (Das et al., 2006a).  These Müller glia-derived neurospheres express neural 
stem cell markers, including Sox2, Nestin and Musashi1, and are able to generate 
secondary and tertiary spheres, demonstrating their ability to self-renew. Furthermore, when 
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induced to differentiate through the removal of FGF2 and the addition of serum, these cells 
are able to change their morphology adopting more of a neuronal phenotype, as well as 
giving rise to both neurons and glia. Finally, when dissociated and transplanted in vivo, these 
cells migrate into the recipient retina although the evidence to indicate that they form new 
photoreceptors is limited.  
 
Components of the Wnt and Notch signalling pathways are upregulated in Müller glia 
enriched cultures derived from the normal adult rat retinas (Das et al., 2006a). In keeping 
with this, exogenous supplementation with Wnt2a significantly increases the generation of 
neurospheres from these cells, whereas there is a notable decrease when cultured with the 
Wnt antagonist, Fzd-CRD. Likewise, when enriched Müller glia cultures are transfected with 
NICD to constitutively activate the Notch pathway, there is a significant increase in 
neurosphere production (Das et al., 2006a). Interestingly, the presence of antagonists of 
either the Wnt or the Notch signalling pathway results in a lower number of neurospheres 
than controls, implying that endogenous Wnt and Notch signalling is required for the 
maintenance of stem cell properties of these enriched Müller glia cells (Das et al., 2006a). 
Inactivation of the tumour suppressor gene p53 significantly increases the proliferation of 
these cells, believed to be due to the nuclear accumulation of -catenin and Yap protein in 
the p53-/- Müller glia-derived retinal progenitors (Zhao et al., 2014). Importantly, and of 
relevance for transplantation studies, when these cells are transplanted into host animals, 
they can integrate and express either retinal ganglion cell or photoreceptor markers, such as 
Islet1 and Brn3, or Rhodopsin and IRBP, respectively. Furthermore, despite the lack of the 
tumour suppressor gene, these cells do not generate tumours, aligning with the fact that 
there are no documented cases of tumours of Müller glia cell origin (Zhao et al., 2014).  
 
A population of Müller glia cells with stem cell characteristics has been isolated from the 
adult human retinae, suggesting that this regenerative capacity may be utilised in response 
to injury or disease (Bhatia et al., 2009; Lawrence et al., 2007). While there is no evidence to 
currently suggest that they can contribute to regeneration in vivo, they can be induced to 
grow and differentiate in vitro. In a recent study, Singhal and colleagues transplanted retinal 
ganglion cells derived from human Müller glia cells into the eyes of Lister hooded rats 
previously depleted of retinal ganglion cells by NMDA and reported an improvement of the 
negative scotopic threshold response of an ERG (indicative of RGC function) (Singhal et al., 
2012). Subsequently, it has been shown that it is also possible to generate photoreceptor-
like cells from human Müller glia cells. When transplanted into P23H rat, a rodent model for 
primary photoreceptor degeneration, these cells are able to migrate and integrate into the 
retina, and potentially improve photoreceptor function in vivo, as indicated by an increase in 
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a-wave amplitude and slope of the scotopic flash ERG (Jayaram et al., 2014) These results 
suggest that human Müller glia stem cells isolated from the normal adult retina might be 
cultured in vitro to generate a source of retinal cell types suitable for transplantation studies. 
However, a challenge for this source is that it is unlikely to be any more plentiful than those 
from human embryonic sources, necessitating highly efficient expansion strategies and 
potentially limiting their use as a donor source for transplantation.     
7.3. Overview of Ocular-Derived Donor Cells – Limitations 
 
The discussion above shows that there exists in the literature a wide array of protocols 
aimed at generating specific retinal cells types, typically photoreceptors, from ocular stem 
cell-like sources. As we move towards more effective differentiation protocols, such as those 
described in the next section, these cells still represent a viable source for autologous 
transplantation. There remain a number of issues to resolve, however. These include 
whether such sources can generate donor cells in the numbers required for effective 
transplantation. Moreover, it is not yet known how faithfully these newly generated cells 
reflect their new phenotype, whether they retain aspects of their initial identity or how stable 
their newly acquired identity is over time. Further studies are also required to verify the true 
functionality of these cells, as well as their integration and survival capabilities in vivo.  
8. Directed Differentiation of Pluripotent Stem Cells to Generate Transplantation-
Competent Donor Cells 
 
Pluripotent stem cells are an attractive alternative to ocular-derived stem cell populations as 
a source of donor cells (Figure 1c-d). Although ineffective for photoreceptor transplantation 
in their undifferentiated state, they represent a potentially inexhaustible source of donors, if 
we are able to fully recapitulate retinal development in vitro to a developmental state 
equivalent to the period of photoreceptor genesis. In the early 1980’s, two independent 
laboratories published reports describing the isolation of pluripotent ESC lines from the inner 
cell mass of murine blastocysts (Evans and Kaufman, 1981; Martin, 1981) (Figure 1d). ESCs 
are characterised by a number of key properties. They can be maintained indefinitely in an 
undifferentiated state in vitro, demonstrate the capacity to differentiate into cells from all 
three germ layers (endoderm, mesoderm and ectoderm) and following their introduction into 
the pre-implantation stage embryo, they give rise to chimeric animals. Fifteen years later, 
human embryonic stem cells (hESCs) had also been isolated (Thomson et al., 1998), 
initiating a wave of interest in ESCs as a possible source for cell replacement therapies.  
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The development of iPSCs technology represents a new autologous source of cells (Figure 
1c). Importantly, iPSCs also offer a new source of human cells for studying human 
development, physiology and a number of pathologies. In 2007, Takahashi and Yamanaka 
reported that, from a screening of 24 different factors, just four transcription factors (Oct4, 
Sox2, c-Myc and Klf4) are necessary to reprogram human fibroblasts into iPSCs. These 
cells possess many features similar to ESCs, including morphology, self-renewal ability and 
the capacity to form teratomas (Takahashi et al., 2007). Since then, iPSC technology has 
evolved and there are now many reports of iPSCs that are similar, albeit not identical, to 
ESCs, not only in gene expression but also in miRNA expression, DNA methylation and 
histone modification patterns. Importantly, iPS cell lines capable of generating adult 
chimeras with germ line transmission have been described (Gai et al., 2009; Hamanaka et 
al., 2011; Maherali et al., 2007; Okita et al., 2007; Wernig et al., 2007). Moreover, somatic 
cells can now be reprogrammed into iPSCs using a variety of approaches, including 
integration-free methods, such as Sendai virus, episomal plasmids, recombinant proteins 
(Kim et al., 2009) and small molecules [(Zhou et al., 2009); see review (Borooah et al., 
2013)].  
 
Fibroblasts are the most common source of cells for reprogramming, although a number of 
tissues can now be utilised to derive iPS cell lines, including blood (Loh et al., 2009), 
keratinocytes (Aasen et al., 2008), cord blood cells (Giorgetti et al., 2009), and even adult 
neural stem cells (Kim, 2007). Furthermore, the differentiation status, i.e. the epigenetic state 
of the somatic cells chosen, appears to influence not only the reprogramming efficiency but 
also the potential of the cells to differentiate into the desired cell type for therapy (Kim et al., 
2010). Hematopoietic stem cells, for example, are reprogrammed into iPSCs much more 
efficiently than fully differentiated lymphocytes (Eminli et al., 2009). In the eye, foetal RPE 
has also been reprogrammed into iPS cell lines. When compared to other iPS and ES cell 
lines for their capacity to generate RPE colonies in vitro following differentiation, the human 
foetal RPE-derived iPS cell lines have been shown to perform superiorly (Hu et al., 2010).  
 
The success of future cell replacement therapies will likely depend on the right choice of the 
initial pluripotent population and the ability to efficiently guide these cells towards the 
required differentiated cell type. The generation of reliable and robust differentiation 
protocols that can be used with either ES or iPS cell lines is, therefore, of great importance. 
There has been very significant progress to this end over the last 10 years, which we 
discuss below.  
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8.1. Obtaining Retinal Cells from Pluripotent Stem Cells 
 
Evans and Martin both demonstrated that upon exposure to serum, floating embryoid body 
(EB) cultures of ESCs undergo differentiation and generate many cells types from the three 
germinal layers. However in these studies, the presence of neural tissues was not 
pronounced (Evans and Kaufman, 1981; Martin, 1981). Since then, there has been intense 
investigation into protocols for the generation of neural lineages from mouse ESCs (Bain et 
al., 1995; Kawasaki et al., 2000; Lee et al., 2000; Mizuseki et al., 2003; Wichterle et al., 
2002; Ying et al., 2003). To date, there are two main methods for the differentiation of 
pluripotent stem cells into multi-lineages. The first protocol encompasses ESC differentiation 
in a monolayer (2D method) culture, while the second approach relies on the formation of 
cell aggregates, or EBs, grown in suspension. The differentiation potential into different cell 
fates is further determined by modifications to the culture environment, such as the addition 
of growth factors, serum concentration, nutrient limitation and ECM (Kurosawa, 2007) 
(Figure 2c).  
 
As described in section 4.1, in normal development the eye is specified in a stepwise 
manner, commencing with commitment to a telencephalic identify, followed by formation of 
the eye field (Figure 2a). One of the first studies to report the generation of ESC-derived 
retinal cell types was based on methods for neural differentiation. In a study by Zhao et al., 
neural progenitor differentiation was induced either by the addition of RA or insulin-
transferrin-selenium fibronectin (ITSFn) and basic FGF (bFGF) to cultures (Zhao et al., 
2002). Further differentiation into photoreceptors was achieved by co-culture with postnatal 
(P1) retinas. This study provided a proof-of-concept for ESC differentiation into cells that 
express markers of rod photoreceptors.  
  
Subsequently, efficient telencephalic differentiation of mouse ESCs was demonstrated by 
using a serum-free floating culture of EBs (SFEB) system. Under these conditions, further 
treatment of SFEB cultures with Wnt and Nodal antagonists, Dickkopf-1 (Dkk-1) and LeftyA 
(SFEB/DL), respectively, improved the efficiency of Bf1-positive telencephalic cell generation 
considerably (nine-fold increase over 15% as opposed to 1.6%) (Watanabe et al., 2005). 
During early embryonic patterning, Wnt signalling mediates dorsal-ventral patterning of the 
embryo, whilst Nodal signalling is involved in both anterior-posterior and left-right patterning. 
Specifically, Dkk-1 is a secreted protein, which has been shown to be necessary for head 
induction (Glinka et al., 1998) and Lefty is understood to be important in regulating the range 
and duration of Nodal activity (Sakuma et al., 2002). As such, the combination of both 
factors was sufficient to generate ESC-derived neural and rostral populations. 
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Finally, further differentiation of these cells towards a Rax/Pax6-positive retinal lineage has 
been achieved when the SFEB/DL-generated telencephalic EBs were treated with 5% serum 
and activin-A (SFEB/DLFA) at initial stages of culture [Figure 2c; (Ikeda et al., 2005)]. In this 
work, Ikeda and colleagues examined a number of factors known to be important in retinal 
development, including Shh, Wnt, BMP4, Nodal (without LeftyA), IGF, FGF1, FGF2, and 
FGF antagonists for their ability to induce Rax-positive retinal progenitors. However, only 
serum and activin-A were shown to induce significant retinal-directed differentiation. The 
mechanism of action of these two factors in early eye development has yet to be elucidated. 
Nevertheless, ~26% of generated cells expressed markers of RPCs and were able to 
differentiate into Crx-positive photoreceptor precursors. When cultured with embryonic 
retinal cells, SFEB/DLFA differentiated ES cells gave rise to a small number Rhodopsin and 
Recoverin positive cells, able to migrate into retinal explants in vitro. This was the first study 
to demonstrate the systematic and stepwise in vitro differentiation of ESCs into rostral 
neuronal progenitors, followed by progression to retinal progenitors, and finally 
photoreceptor precursors. 
 
Since then, a number of studies have combined the idea of sequential specification, starting 
with the induction of a telencephalic, followed by retinal, identity. Lamba et al. reported the 
first differentiation of hESC into RPCs using this concept [Figure 2c; (Lamba et al., 2006)]. In 
this study the authors employed the Wnt antagonist, Dkk-1, as described above, a BMP 
antagonist, Noggin, and IGF-1. During normal stages of development, both Noggin and Dkk-
1 act as neural inducers (Smith and Harland, 1992). IGF-1 is another head inducer factor, 
which functions in a manner similar to Dkk-1 by antagonising Wnt signalling in the early 
developing embryo. In Xenopus, overexpression of IGF-1 leads to the formation of ectopic 
eyes (Richard-Parpaillon et al., 2002). Following an initial brief suspension culture where 
neural induction was stimulated, EBs were plated on poly(D-lysine) and Matrigel for further 
differentiation. The cells were cultured in the continued presence of Dkk-1, Noggin and IGF-
1, with the addition of bFGF. Under these conditions, the differentiated cultures contained 
about 80% RPCs and 12% were CRX-positive photoreceptor precursors after three weeks in 
culture (Lamba et al., 2006). It is worth noting that this is significantly faster than  normal 
human eye development, where the first CRX-positive photoreceptor precursors would not 
normally be seen until week ten (O'Brien et al., 2003).  
 
The protocol described by Lamba yields a high percentage of RPC-like cells in a relatively 
short time frame. However, the inclusion of the basement membrane matrix, Matrigel, which 
contains a number of unspecified growth factors, is likely to influence differentiation and, 
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potentially, the duration of differentiation. For ESCs to be used in the clinical setting, it is of 
paramount importance to have precisely defined culture conditions capable of inducing 
retinal specification. This was achieved a couple of years later by Osakada et al. This team 
was the first to describe defined culture conditions that promoted photoreceptor 
differentiation from mouse, monkey and human ESCs [Figure 2c; (Osakada et al., 2008; 
Osakada et al., 2009b)]. Their protocol was based on the SFEB/DLFA method described by 
Ikeda et al., which was used to generate RPCs from a mouse ES cell line where GFP was 
knocked in at the Rax locus. Rax-positive RPCs were isolated by FACS and further cultured 
on poly-D-lysine/laminin/fibronectin-coated dishes. Inhibition of Notch signalling has been 
shown to promote photoreceptor differentiation in vivo (Jadhav et al., 2006; Yaron et al., 
2006). Accordingly, Osakada et al. found that the addition of the γ-secretase inhibitor, DAPT 
increased the number of Crx-positive photoreceptors precursors. Of note, the addition of 
DAPT at the early RPC stage, when the retinal progenitors were still dividing, led to a 
decrease in the number of mitotic cells and a concomitant increase in early born ganglion 
cells and Crx-positive photoreceptor precursors. All other retinal cells, including horizontal, 
amacrine, bipolar, immature Müller cells and immature RPE, were present in these cultures, 
with no significant changes in their numbers or ratios following DAPT treatment. Therefore, 
DAPT appears to direct the mitotic RPCs toward differentiation to post-mitotic photoreceptor 
precursors and ganglion cells. To further improve photoreceptor differentiation, the addition 
of a cocktail of factors (acidic FGF, basic FGF, taurine, Shh and RA) known to be involved in 
rod genesis during development, was assessed. In agreement with the developmental 
studies, the presence of these extrinsic factors enhanced rod photoreceptor differentiation 
with approximately 17% of total cells expressing the photopigment Rhodopsin. 
 
One of the most elegant and comprehensive descriptions of the stages of retinal 
differentiation arising from human ES and iPSCs is that of Meyer et al. (Meyer et al., 2009). 
In this study, a combination of suspension and adherent two-dimensional (2D) cultures was 
used. A striking difference with this, compared to previous protocols, is that no inducible 
factors were added to the suspension culture and retinal differentiation was, instead, 
achieved by endogenous secretion of Dkk-1, Noggin and FGF signalling. Following a period 
in suspension, cell aggregates were plated on laminin and allowed to form neuroepithelial 
rosettes, which were then mechanically isolated to grow as suspension structures again. 
This combination of suspension/ 2D-adherent culture conditions proved to be very effective 
in producing RPCs and CRX-positive photoreceptor precursors in a temporal order that 
closely mimics normal development. Further improvement of this protocol permitted the 
differentiation of human ESC and iPSC-derived optic vesicles (OV-structures), which could 
be separated from neural forebrain-like regions [Figure 2c; (Meyer et al., 2011)]. Following 
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separation, the OV-structures continued to mature and differentiate and by day 80 of culture, 
photoreceptors expressed CRX and RECOVERIN. Of worth, these studies did not 
demonstrate the presence of more mature RHODOPSIN-positive photoreceptors, 
questioning whether further modifications to these protocols are required. 
 
The most striking and efficient protocol for the differentiation of retinal tissue was developed 
by Sasai and colleagues [Figure 2c; (Eiraku et al., 2011)]. Using a three-dimensional (3D) 
culture system, mouse ESCs prepared in the previously described SFEB system form EBs, 
which are then cultured in suspension with Matrigel (growth factor reduced [GFR]) from day 
1 of culture. These conditions permitted the spontaneous formation of self-organised retinal 
neuroepithelia, which remarkably, evaginates into optic vesicle-like structures expressing the 
retinal specific progenitor marker, Rax, that in turn invaginates to form bilayered optic cup-
like structures during the first week of culture.  This was the first time that retinal 
development, including morphogenesis, had been replicated in vitro from ESCs. Most 
remarkably, and contrary to what would have been predicted from our understanding of 
retinal development in vivo, this process occurs in the absence of neighbouring tissues, such 
as surface ectoderm, lens and mesenchymal tissue. Consequently, Eiraku et al. propose 
that the signals and physical forces drive retinal differentiation are intrinsic to these cells and 
the neuroepithelium being formed.  
 
Further retinal development was achieved when the optic cup-like structures were manually 
isolated from the floating EBs (Eiraku et al., 2011). The isolated optic cups spontaneously 
formed large, continuous epithelial structures, which showed a clear apical-basal 
stratification similar to the early postnatal retina. Following a further two weeks of 
differentiation, all the cell types of the mature retina were detected, with photoreceptors 
present in the outermost layer (facing the media environment) and other cell types overlying 
them towards the basal surface of the neuroepithelium (facing the inside of the vesicle). In 
this study, the only external inductive signals introduced into this culture system came from a 
short pulse of RA and taurine added to the differentiation culture from days 10 to 14. RA 
appears to be very important in maintaining the integrity of the epithelium, since the absence 
of RA in these cultures led to the loss of lamination, with only neural rosette-like structures 
remaining. This study represents a landmark in the generation of neural tissues from ESCs. 
Nonetheless, the conditions still require improvement; there is a loss of neural integrity after 
35 days in culture, and these conditions are unable to support the full maturation of 
photoreceptors, particularly the formation of outer segments. 
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Of clinical relevance, a very similar 3D-based differentiation protocol using human ESCs, 
has been described by the same group [Figure 2c; (Nakano et al., 2012)]. Similar to the 
mouse ESC differentiation cultures, these cultures were also dependent on GFR-Matrigel 
and generated optic cup–like structures that self-organised into a stratified neural retina 
containing all retinal cells, including cone and rod photoreceptors. In contrast to mouse 
ESCs, a higher concentration of knock-out serum (KSR) was required to derive human 
retinal epithelium. However, this higher concentration of KSR also triggered an undesired 
caudalisation of neural progenitors. To solve the problem and drive differentiation to a more 
rostral phenotype, a Wnt inhibitor, IWR1e, was added together with the ROCK inhibitor, Y-
27632, from day 0 of culture. The number of RAX-positive retinal progenitors was further 
improved when serum and the Hh agonist smoothened agonist, SAG, were added to early 
stages of culture. By day 42, CRX-positive photoreceptor precursors were present in the 
neuroepithelium region and 20 days later these cells started to express RECOVERIN. By 
day 126 in culture, the authors report the expression of markers characteristic of more 
mature photoreceptors, including NRL and RHODOPSIN. A comprehensive time-course of 
photoreceptor genesis was not performed in this study, so it is not clear when the onset of 
this expression occurred. Importantly, and in keeping with the mouse ESC 3D cultures 
described by the same group, no outer segment formation was observed despite the 
extended periods of culture.  
 
Over the same period, a variety of retinal differentiation protocols for mouse and human iPS 
cells have also been described (Hirami et al., 2009; Homma et al., 2013; Jin et al., 2012; 
Lamba et al., 2010; Mellough et al., 2012; Meyer et al., 2009; Osakada et al., 2009a; 
Osakada et al., 2009b; Parameswaran et al., 2010; Phillips et al., 2012; Reichman et al., 
2014). Hirami and colleagues described one of the first protocols for photoreceptor 
differentiation from mouse and human iPS (Hirami et al., 2009). A 2D protocol similar to 
those described for ESCs was used, and included Wnt and Nodal inhibition, supplemented 
in parallel with RA and taurine. This was sufficient to drive mouse iPS cells towards a 
photoreceptor fate. Hirami et al., and others, have also described the differentiation of 
human iPS cells towards this fate, although efficiency is typically lower than that achieved 
with mouse iPS cells (Hirami et al., 2009; Lamba et al., 2010; Osakada et al., 2009a). 
Phillips et al. (Phillips et al., 2012) generated a human iPS cell line from reprogrammed 
blood cells and demonstrated the formation of retinal OV-structures using the Meyer 
protocols (Meyer et al., 2009; Meyer et al., 2011). Although the retinal epithelium contained 
RECOVERIN-positive photoreceptors by around day 70 of culture, the presence of late 
markers, such as OPSINS, were only detected when these vesicles were dissociated and 
the cells plated on laminin for further culture. Additionally, our group has demonstrated the 
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differentiation of human ESC and iPS cells into RPCs and photoreceptor precursors using a 
Matrigel-based adherent culture system where neuroepithelia-containing vesicles form very 
early in culture (day 2). Under these conditions, the integrity of the neuroepithelium was lost 
very quickly, although markers of photoreceptor precursors, such as CRX and NRL, were 
detectable 30 days after plating (Boucherie et al., 2013). 
 
Recently, Zhong et al. (Zhong et al., 2014) reported further adaptations of the Meyer 
protocols (Meyer et al., 2009; Meyer et al., 2011; Phillips et al., 2012) and demonstrated that 
human iPS cell lines can efficiently form neuroepithelium containing retinal structures. Again, 
this protocol consisted of a stepwise 2D-suspension/3D-suspension differentiation system 
that is not dependent on exogenous factors at the initial suspension phase; although it does 
require the addition of GFR-Matrigel (Figure 2c). This study demonstrates for the first time 
the long-term (up to 180 days) culture of intact retinal neuroepithelial morphology. This 
appears to be dependent on the presence of serum, taurine and RA. Most importantly, 
photoreceptor maturation was improved by the addition of RA to these cultures during a 
specific time window (week 10 to 14 of culture). Furthermore, convincing evidence from 
electron microscopy images of the mature neuroepithelia regions showed the presence of 
developing outer-segment discs, albeit in low numbers. In agreement, perforated-patch 
clamp experiments demonstrated that a couple of photoreceptor cells, tested between week 
25 and 27 of culture, were responsive to light. Collectively, this was the first study to 
demonstrate outer segment formation in vitro. Of note, these structures formed despite the 
RPE in close apposition to the nascent photoreceptor layer, questioning the whether the 
proximity of the RPE is truly necessary for photoreceptor maturation. Most recently, 
Reichman et al. described a very simple differentiation protocol that allows human iPS cells 
to overgrow under neuralising conditions and both RPE and neuroepithelia vesicles 
containing photoreceptors were observed after three weeks in culture (Reichman et al., 
2014).   
 
The differentiation of mouse and human pluripotent stem cells towards photoreceptor 
lineages has progressed rapidly in the last decade. A robust number of photoreceptor 
precursors as well as a small number of more mature and functional photoreceptors can now 
be obtained from human stem cells using a variety of step-wise differentiation protocols. This 
includes a number that take significant steps towards clinical application, reducing the need 
for serum and factors with unspecified content, such as Matrigel. It is important to emphasise 
the long time required to generate photoreceptors with the more robust and efficient 
differentiation protocols available. Further improvements, which aim to accelerate the 
differentiation of photoreceptors, are likely to be necessary for clinical approaches. An 
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additional consideration, which is perhaps more pressing, is the need for a careful 
characterisation of the stages of development of these human ESC-derived photoreceptors, 
as we know from mice studies that only stage-specific photoreceptor precursors are capable 
of integrating into the adult retina efficiently (see section 6.1.). Whether or not the same 
holds true for human photoreceptors remains to be determined. 
 
8.2. Transplantation of Embryonic and Induced Pluripotent Stem Cell-Derived 
Photoreceptors 
 
In the previous section, we described recent advances in generating pluripotent stem cells 
(PSC)-derived photoreceptors and conclude that we can now generate sufficient numbers of 
photoreceptors for transplantation experiments. To date, only a relatively small number of 
studies have transplanted ESC-derived retinal cell types (Banin et al., 2006; Gonzalez-
Cordero et al., 2013; Lamba et al., 2009; Lamba et al., 2010; Tucker et al., 2011; West et al., 
2012; Zhou et al., 2011). The large body of work on transplantation using early postnatal 
cells from mice has established a number of parameters required to increase the number of 
integrated cells following transplantation; these include both the number and purity of the 
transplanted population (Table 1).   
 
One of the first transplantations of ESC-derived-retinal cells was performed with cells 
derived from hESCs. Following three weeks of hESCs retinal differentiation (Lamba et al., 
2006), Lamba et al. (Lamba et al., 2009) transplanted a virally labelled GFP-positive mixed 
population of retinal cell types (between 50,000-80,000) to the subretinal space of adult wild 
type and Crx-/- mice, a model of retinal degeneration that lacks both rod and cone function 
(Furukawa et al., 1999). Within this mixed population, the differentiated cells were reported 
to contain 80% retinal cells, of which 30% were CRX-positive and 15% were NRL-positive, 
indicating that at least a small proportion were at a stage equivalent to post-mitotic rod 
precursors in the developing retina. Following transplantation into wild type and Crx-/- retinas, 
GFP-positive cells were observed in all layers of the retina and a small number of cells were 
correctly located in the ONL. In the Crx-/- animals, donor cell identity was confirmed using a 
human-specific NRL antibody and an average of 3,000 cells located within the ONL were 
counted per eye. These cells did not appear to form new outer segments. This may not be 
surprising since donor cells frequently adopt an atypical morphology in severely degenerated 
retinas (Barber et al., 2013). Lamba et al. assessed connectivity and functionality of the 
transplanted cells into the endogenous circuitry by ERG. Despite the low number of 
 56 
integrated photoreceptors, the transplanted Crx-/- eyes showed a light response with b-wave 
restoration (Lamba et al., 2009).  
 
Another study by the same group demonstrated the differentiation of a human iPS cell line 
towards photoreceptor cell fate. Approximately 12% of the differentiated cells were CRX-
positive, with 1% of all cells in culture expressing late postnatal markers, RECOVERIN and 
RHODOPSIN. In order to purify and isolate photoreceptors only, the cells were labelled and 
FAC sorted for the human photoreceptor specific promoter IRBP driving GFP (IRBP-GFP), 
introduced by lentiviral vectors. Following transplantation into adult wild type eyes, 
approximately 50 cells per eye were shown to migrate into the ONL. However, no inner 
processes projecting towards the INL, or inner and outer segments were present (Lamba et 
al., 2010).  
 
A mouse DsRed iPS cell line has also been used to differentiate photoreceptor precursors 
with a protocol that used a cocktail of growth factors and recombinant proteins (Tucker et al., 
2011). In this study, ~250,000 retinal cells at day 33 of differentiation were transplanted into 
the Rho-/-, a model that lacks Rhodopsin protein. Importantly, to avoid teratoma formation, 
these cultured cells were first depleted of cells positive for the SSEA1 marker of 
undifferentiated ESCs. There, the authors described a repopulation of the ONL following 
transplantation with an average of 16,000 cells integrated into the ONL. This is particularly 
striking since transplantation of post-mitotic rod precursors from the postnatal retina leads to 
the integration of only 500-1,000 donor cells, three weeks post-transplantation (Barber et al., 
2013). The DsRed photoreceptors were positive for Rhodopsin, which is absent in the host 
photoreceptors, and expressed Recoverin and the outer segment markers, ROM1. Similar to 
results obtained by Lamba et al., the authors reported a restoration of ERG response post-
transplantation. Interestingly, correct morphology does not appear to be a prerequisite for 
function. A recent report demonstrated that photoreceptors with profound structural deficits, 
including the absence of fully formed outer segments, are still able to support significant 
levels of visual function. Moreover, functional read-outs, including ERG amplitudes, can be 
markedly better than might be predicted from the level of Opsin expression and segment 
formation (Thompson et al., 2014). Together, these findings point to the functionality of stem 
cell-derived photoreceptors; however, further work is required to demonstrate whether or not 
they can improve vision.   
 
We recently reported an adaptation of the Osakada SFEB/DLFA differentiation protocol; this 
involved forming individual EBs in 96-well plates and establishing the optimal cell density for 
the generation of Rax-positive retinal progenitors, which consequently led to the generation 
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of several different retinal cells types, including photoreceptors (West et al., 2012). Our 
findings have demonstrated the important role of the differentiation niche; cultures containing 
only RPCs, as determined by the expression of Rax.GFP, resulted in a greater number of 
Rhodopsin-positive cells than when RPCs were grown together with other neuronal cell 
types. Thus, a differentiation culture containing a pure population of RPCs is important for 
efficient photoreceptor differentiation. This 2D method of differentiation has been shown to 
generate cell populations in which all the aggregates contain Crx-positive cells (> 65% of 
cells were Crx-positive) by day 24, a finding that has been corroborated by quantitative 
polymerase chain reaction (qPCR) data. Under these culture conditions, the levels of Crx 
transcripts at day 28 were comparable in levels to that of the early postnatal (P0) retina. 
However, of these Crx-positive photoreceptor precursor cells, only a small proportion stained 
for the more mature photoreceptor markers, Rhodopsin and Recoverin. Moreover, when an 
Nrl.RFP ES cell line was used to both determine the precise onset of rod photoreceptor 
differentiation and allow for the isolation of a pure photoreceptor precursor population for 
transplantation, we found that there were very few Nrl expressing cells, despite the presence 
of many Crx-positive cells. This was further underlined by transplantation experiments. 
Following transplantation of 200,000 FAC sorted GFP-positive retinal cells, labelled with 
AAV2/9.CMV.GFP virus, into the subretinal space of adult mice, no integrated cells were 
observed. Together, these results indicated that the defined SFEB/DLFA method of 
differentiation is unable to accurately recapitulate retinal development, at least for the correct 
adoption of photoreceptor fate, nor be scaled up sufficiently to produce large numbers of 
transplantation competent photoreceptor precursors.  
 
As mentioned above, in 2011, Sasai and colleagues reported the near-normal histogenesis 
of retinal neuroepithelium using a 3D culture system (Eiraku et al., 2011). In 2013, we 
reported the first study assessing the transplantation competence of mouse ESC-derived 
photoreceptors generated using an adapted version of the Eiraku protocol (Gonzalez-
Cordero et al., 2013). To scale up the protocol to produce high numbers of photoreceptors 
for transplantation, the EBs were kept as intact structures (whole EBs), as opposed to the 
manually isolated optic vesicles described by Eiraku et al. Additionally, serum free culture 
conditions containing RA and taurine at normal levels of O2 were shown to be more 
conducive to retinal development, allowing for the formation of inner and outer nuclear layer-
like structures containing mature retinal cell types, including photoreceptors. In our study, a 
precise characterisation of rod genesis in the 3D differentiation cultures established that 
ESC-derived rods are similar to early postnatal stages of development (with day 26 of 
cultured cells corresponding to P4-P6 of development). Importantly, this demonstrates that 
the timing of photoreceptor development in 3D cultures closely follows normal in vivo 
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development. Furthermore, the authors demonstrate that ESC-derived rods went on to 
develop features of mature photoreceptors, as indicated by the presence of late markers of 
the phototransduction cascade, r -transducin and Peripherin. This stage of culture is 
therefore more similar to the P10-12 stages of development. Finally, it was shown that inner 
segments and cilium-like structures were observed by electron microscopy, although the 
formation of outer segment-like structures was not detected. Most recently, Roska, 
Busskamp and colleagues have recently reported the formation of outer segments, together 
with inner segments and connecting cilia, and light-evoked electrical responses from mouse 
ESC-derived retinal cultures following the expression of two microRNAs, miR-182 and miR-
183 (Busskamp et al., 2014).  
 
In the study by Gonzalez-Cordero et al., ESC-derived photoreceptor precursors were virally 
labelled with AAV2/9.Rhodopsin.GFP and purified by FACS. Sorted rods (200,000 cells per 
eye) were then transplanted to the subretinal space of the adult Gnat1-/- mouse model of 
degeneration (Figure 4). Using this method, ESC-derived photoreceptors were reported to (i) 
migrate and integrate into the appropriate location in the ONL, (ii) display morphology of 
mature rod photoreceptors, (iii) form synapse-like contacts with bipolar cells within the INL 
and (iv) contain the phototransduction protein rod α-transducin, which is absent in the 
photoreceptors of the host retina. It was also demonstrated that ESC-derived photoreceptor 
precursors could integrate in the Prph2rd2/rd2 and, to a certain extent, the Rho-/- models of 
degeneration in a manner similar to other studies (Barber et al., 2013). Importantly, cells 
isolated from earlier cultures (days 26-29), comparable to early postnatal stages in the 
mouse and hence representing a more immature rod photoreceptor phenotype, integrated in 
higher numbers than those isolated from late cultures (day 34). In this regard, the ESC-
derived photoreceptor precursors behaved very similarly to the freshly dissociated Nrl.GFP-
positive photoreceptor precursors from postnatal retinas (MacLaren et al., 2006; Pearson et 
al., 2012). However, despite these similarities, it is important to emphasise that an average 
of just 500 integrated photoreceptors were observed three weeks post-transplantation in the 
Gnat1-/- recipient, compared to an average of 5,000-10,000 cells following single injections of 
donor photoreceptors from P4-8 mice retinas. Given these low numbers of integrated cells, 
no visual rescue assessments were attempted in this study.  
 
In close agreement with Gonzalez-Cordero et al., Arsenijivic and colleagues, reported 
findings using a mouse ESC-line obtained from the Crx.GFP mouse. They reported that, 
following transplantation, developmentally stage-specific photoreceptors obtained from the 
3D culture system migrate and integrate within the recipient retina (Decembrini et al., 2014). 
These Crx.GFP-positive cells were transplanted subretinally into the immunodeficient non-
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obese diabetic/severe combined immunodeficient (NOD/SCID) adult retina. Photoreceptors 
derived from day 25 cultures integrated within the recipient ONL in higher numbers than 
donors taken from day 30 cultures. Decembrini et al., reported numbers of integrated cells 
very similar to those reported by Gonzalez-Cordero et al. despite the use of immune 
deficient animals, suggesting that these non-autologous cells are not subject to immune 
rejection, at least at one month post-injection (Decembrini et al., 2014).  
 
Another approach for cell replacement strategies involves the transplantation of retinal 
sheets, rather than dissociated cells. This strategy could be of considerable interest, 
particularly for the treatment of very severe degenerations where the entire ONL is absent. It 
has a distinct advantage over cell transplantation in the potential extent of photoreceptor 
replacement. A number of groups have examined the potential for transplanting retinal 
progenitor and full thickness retinal sheets, some including RPE. Collectively, these studies 
show graft survival, connectivity and function in animal models [reviewed by (Seiler and 
Aramant, 2012)] and patients receiving retinal progenitor sheet transplants demonstrated 
improvements in vision (Radtke et al., 2008). As yet, it is unclear to what extent normal 
visual processing will be affected by the inclusion of inner retinal neurons within the retinal 
sheet. Silverman and colleagues pioneered techniques to derive photoreceptor sheets from 
adult and early postnatal retina (Silverman et al., 1992; Silverman and Hughes, 1989a; 
Silverman and Hughes, 1989b; Silverman and Hughes, 1990). Ghosh and colleagues 
(Ghosh et al., 1999) reported limited success following the transplantation of partial-
thickness sheets into the rabbit, most probably due to damage incurred during tissue 
processing. Unfortunately such isolation techniques necessarily induce trauma to the tissue. 
A second, more practical issue is the surgical logistics of getting a fragile tissue sheet into 
the recipient subretinal space and ensuring that it lies flat against the recipient neural retinal 
surface. Supply of fetal donor tissue is, inevitably, limited. Interestingly, however, Takahashi 
and colleagues adapted the Eiraku/Sasai 3D-differentiation protocol to differentiate mouse 
ES or iPS cells into neuroepithelium structures containing a defined ONL (Assawachananont 
et al., 2014). Subsequently, these mES/iPSC-derived retinal sheets, obtained from 
differently-staged cultures [young (day 11-17) and old (day 18-24)], were transplanted into 
the Rd1 mouse, an animal model for rapid and severe degeneration in which the ONL is 
almost completely lost by three weeks (Lolley et al., 1994). Following transplantation, 
photoreceptor precursors in the transplanted ONL were shown to form inner and outer 
segments, as demonstrated by the presence of Recoverin and Rhodopsin. Furthermore, the 
authors evaluated the integration potential of these sheets with the host retina by analysing 
the connection with the host bipolar cells via immunostaining for PKC. They observed two 
possible outcomes; in some instances, the transplanted stem cell-derived neuroepithelium 
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contained an INL and, therefore, interneurons were present between host INL and 
transplanted ONL. However, when the transplanted sheets did not contain a proper INL, the 
ESC-derived ONL readily contacted the host INL. Under these circumstances, the donor 
photoreceptors make physical contacts with the host bipolar cells. Further studies are 
required to determine whether these represent functional synaptic connections and whether 
these ESC-derived photoreceptor sheets are able to drive visual function. Another important 
consideration is the contact between the transplanted photoreceptors’ newly formed outer 
segments and the endogenous RPE. Again, while the outer segments from the stem cell-
derived photoreceptors were sometimes well aligned and in contact with the host RPE, other 
regions formed rosettes, which inhibited direct contact with the RPE. In summary, the last 
year has seen the publication of a number of reports from different groups demonstrating the 
competence of mouse ESC and iPSC-derived photoreceptors to survive and make contact 
with the recipient retina following transplantation (Assawachananont et al., 2014; Decembrini 
et al., 2014; Gonzalez-Cordero et al., 2013; Tucker et al., 2013). Improvements in 
transplantation efficiency represent the next essential step; this includes not only improving 
the number of cells that integrate within the diseased recipient retina, but also ensuring their 
continued survival. We must also determine whether these cells truly integrate into the 
recipient retinal circuitry and are capable of driving visual function. Most importantly, the 
recently described human ESC/iPSC-derived photoreceptors (Nakano et al., 2012; Zhong et 
al., 2014) must now be assessed for their capacity to migrate and integrate into the recipient 
retina and whether they can also drive visual function. To date, only one study has reported 
the transplantation of human ESC-derived photoreceptors (Lamba et al., 2009) and therefore 
more detailed transplantation assessments are required to identify the optimal stage of 
maturation for robust integration.   
9. Clinical Perspectives  
 
The prospects for taking photoreceptor replacement therapy towards clinical application look 
promising. The past decade has seen major advances, including the demonstration of visual 
function following photoreceptor transplantation and the generation of transplantable donor 
cells from renewable sources. We have also seen that it is possible to transplant cells into 
even very severely diseased retinas. Nonetheless, there are many significant challenges to 
overcome before taking this into the clinic. The efficiency of donor cell integration after 
transplantation into the diseased retina must be significantly improved, particularly using 
ESC/iPSC-derived sources. Achieving this will undoubtedly require the full elucidation of the 
intrinsic and extrinsic factors regulating photoreceptor development and maturation. Not all 
degenerations are the same and each presents its own set of barriers that may impede the 
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passage of donor cells from the site of transplantation into the recipient retina (see (Barber 
et al., 2013)). The remaining retinal circuitry will also undergo changes that may affect the 
processing of new visual information in an as yet unknown manner. Once there, the 
transplanted cells may, depending upon their source and the level of inflammation in the 
recipient eye, face challenges from the host immune system.  
 
The development of human ESC/iPSC-derived photoreceptor differentiation methods 
suitable for clinical use will be an essential phase of preparation towards future clinical 
studies involving photoreceptor transplantation. Points to consider include the choice of ES 
or iPS cell lines and differentiation protocol to be used, development of storage strategies 
and donor cell isolation and purification methods. Importantly, all of these criteria will need to 
be delivered under good manufacturing practice (GMP) compliant conditions. 
 
While ESCs have a great capacity for expansion and differentiation and, therefore, represent 
a suitable source of cells for transplantation therapies, there are some concerns related to 
immunogenicity. The transplanted population could trigger a host immune rejection and, 
thus, treatments could be compromised (see (Pearson et al., 2014)). Our understanding of 
the host immunological responses following photoreceptor transplantation is still very limited, 
having only been assessed in a handful of studies. A detailed characterisation of the innate 
and adaptive responses following transplantation is required if ESC-derived photoreceptors 
are to be used in clinical settings. The use of donor cells generated from iPS cell lines that 
are human leukocyte antigen (HLA)-haplotype matched may avoid this issue and there are 
many initiatives around the world to set up human iPS cell banks, with such aims in mind.  
 
To take any differentiation protocol forward to clinical application, it must be GMP compliant 
and use clinical grade lines to generate, store and purify human ESC/iPSC-derived 
photoreceptors. The majority of the differentiation protocols discussed in section 8.1 involve 
animal-derived products. Xeno-contaminated cells are unsuitable for transplantation into 
patients because of the risk of zoonoses and the potential activation of animal retroviruses, 
as well as the possibility of immune rejection. Although some xeno-free differentiation 
protocols to generate retinal cell types have been investigated (Sridhar et al., 2013; Tucker 
et al., 2013), there is still much optimisation required before we can generate 
transplantation-competent photoreceptor precursors (or indeed retinal sheets) under GMP-
compliant conditions. The combination of knowledge obtained from donor-derived, mouse 
and human ESC-derived photoreceptor precursor transplantation studies will assist the 
development of a defined scalable, non-xenogeneic protocol for generating, purifying and 
storing hESC-derived photoreceptor precursors. 
 62 
 
The differentiation of human ESC/iPSC-derived photoreceptors requires long-term cultures 
(Nakano et al., 2012; Zhong et al., 2014). This lengthy differentiation is not unexpected if 
compared to human eye development. However, keeping these cultures is not only laborious 
and costly for the researcher but also makes it harder to translate to large-scale 
preparations, required for clinical purposes. Therefore, the development of appropriate 
cryopreservation methods suitable for photoreceptor precursors will be important so that 
cells at the right stage of development can be obtained at any time. It is also extremely 
important to develop a selection strategy for hESC/iPSC-derived photoreceptors that will 
separate these cells from the inherently heterogeneous mix of cells derived from pluripotent 
stem cell cultures. We, and others, previously described the transplantation of mouse 
photoreceptor precursors via selection employing cell surface antigens, CD markers (Eberle 
et al., 2011; Lakowski et al., 2010; Lakowski et al., 2011). Rod photoreceptor precursor cells 
isolated on the basis of CD73+/CD24+ expression integrate into the adult wild type mouse 
retina in numbers similar, or even higher, than cells selected on the basis of Nrl.GFP 
(Lakowski et al., 2011). We are now characterising the presence of these, and other, cell 
surface markers in mouse ESC-derived photoreceptors to establish their potential as 
markers to isolate these cells for transplantation (Lakowski et al., manuscript in revision). We 
are also assessing if the same and/or other cell surface markers are present in stage 
specific human photoreceptor cells. 
 
Importantly, much of the work reported to date has focused on rod transplantation in animal 
models, typically rodents. While it is possible that rod transplantation may benefit patients 
with significant rod loss, the challenges to widespread replacement are significant, as 
mentioned above. A more realistic aim, perhaps, is local replacement, particularly of cone 
photoreceptors. Transplantation of cone or cone-like photoreceptors has been investigated 
in a small number of murine models, but the numbers of integrated cones is markedly lower 
than that of rods (Lakowski et al., 2010; Santos-Ferreira et al., 2014). It will be essential to 
define strategies for the generation of transplantable ESC/iPSC-derived cones. We also 
need to understand the mechanisms governing the integration, maturation and survival of 
these cells following transplantation into the diseased retina. Synaptic connectivity must also 
be considered since correct visual processing relies on the establishment of numerous 
synaptic connections between cones and the inner retina, compared to the almost one-to-
one synaptic connectivity of rods and rod bipolar cells. Cone transplantation raises the 
question of whether rodents, as nocturnal, rod-dominant animals, represent the best model 
on which to test the integration of human photoreceptors. In the absence of alternatives, it is 
logical to continue with these experimental models to identify limitations, particularly within 
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the recipient retina, and to define strategies to overcome them. Nonetheless, we must be 
prepared for many unforeseen challenges when moving to the human retina.  
 
Finally, it is important to remember that cell therapy is just one of a number of novel 
therapeutic strategies under investigation. At this point in time, it is very hard to make 
predictions as to which will be the ‘right’ strategy. More likely, different types of disease will 
most likely be receptive to different strategies, even within a single category, such as RP, 
depending on the precise nature of the resulting degeneration.  
10. Conclusions 
 
Built on a background of more than 50 years of research in retinal development and 
transplantation strategies, the last decade has seen enormous progress in both 
photoreceptor replacement and regeneration strategies. The study of lower vertebrates has 
enabled us to identify populations of cells with stem cell-like potential in ocular structures as 
diverse as the post-mitotic neural retina and the CB. Although it has yet to be shown 
conclusively that these sources are capable of generating transplantation-competent cells for 
photoreceptor transplantation, they do raise the prospect of reactivating endogenous repair 
mechanisms. This has only been possible through our understanding of these mechanisms 
in lower vertebrates, which themselves are very often the reactivation of processes occurring 
during embryogenesis. Restoration of visual function by cell replacement strategies is a real 
possibility. This too has been underpinned by knowledge of photoreceptor neurogenesis, 
permitting the identification of markers that identify transplantation-competent cells. Finally, 
we are now able to direct the generation of structures as complex as the mammalian retina 
from ES and iPS cells in vitro by presenting exogenous stimuli in a pattern that recapitulates 
normal retinal development in a dish. In a time of immense translational progress, it is 
essential that we do not forget that these advances are, almost without exception, built on 
the foundations of basic research into retinal development.  
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Figure 1. Sources of cells for cell-based therapies. 
A. Schematic of a mouse eye demonstrating the main sources of endogenous 
stem/progenitor cells in the eye, which includes the ciliary epithelium (CE), iris, retinal 
pigment epithelium (RPE) and Mϋller glia cells. B. These stem/progenitor cell populations 
also represent an attractive source for cell transplantation studies as they can be expanded 
and cultured in vitro towards a more photoreceptor phenotype. In addition to these ocular 
stem cells populations C. somatic cells, which can be reprogrammed into iPS cells, and D. 
embryonic stem cells (derived from the inner cell mass of the blastocyst) can be isolated, 
expanded and kept in undifferentiated conditions in vitro, prior to differentiation into retinal 
cell types, including photoreceptors, suitable for cell replacement. 
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Figure 2. Eye development and differentiation of pluripotent stem cell protocols. 
A. Schematic demonstrating the various stages of eye development, from the blastocyst 
stage through to the mature adult retina.  At very early stages, the eye field domain is 
specified from a region of the neural plate. This region extends laterally to form the optic 
vesicle, and then invaginates to from the optic cup. Further specification of this region gives 
rise to the young eye, which contains a two-layered optic cup; at this stage, the developing 
neural retina (red) is situated in the inner region of this structure, whereas the RPE forms the 
outer RPE layer (orange). Further differentiation gives rise to the mature retina containing all 
retinal cell types, distributed in their correct laminar position. B. Summary of the main 
signaling factors required for normal eye development, from neural progenitors to retinal 
progenitors and finally photoreceptor precursors. C. Representation of the signaling factors 
used in some of the key ESC/iPS differentiation protocols published to date.  
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Figure 3. Transcriptional control of photoreceptor development. 
A. Schematic representation of the developmental cascade of genes implicated in early eye 
development, with particular reference to B. photoreceptor cell differentiation  
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Figure 4. Transplantation of photoreceptors precursors into the adult retina. 
A. Two main sources of cells for transplantation include photoreceptor precursors from the 
postnatal retina and differentiated embryonic stem cells (see Gonzalez-Cordero et al., 2013 
and Pearson et al., 2012). In each case, the photoreceptors precursors are labeled, typically 
with fluorescent reporters. B. The whole retina and/or ESC-derived EBs are dissociated and 
the photoreceptors are isolate and purified by Fluorescent Activated Cell sorting (FACs). C. 
These purified GFP-positive population of photoreceptors (200,000 cells per injection) are 
then subretinally transplanted between the ONL and RPE. D. Schematic and confocal image 
of integrated GFP-positive mature photoreceptors in the ONL. Six weeks following 
transplantation into a rod  transducing knockout (Gnat1-/- ) animal Nrl.GFP photoreceptors 
form rod -transducin-expressing outer segments and synaptic buttons connecting with the 
endogenous circuitry. These cells can then rescue visual function when excited by light. 
ONL: outer nuclear layer; INL: inner nuclear layer; RPE: retinal pigmented epithelium; OPL: 
outer plexiform layer; IPL: inner plexiform layer; GCL: ganglion cell layer.  
 
 
 
